Accel Entertainment, Inc.

ACEL Q3 2025

Reported: 2025-11-05

Accel Entertainment reported strong Q3 2025 results with a 9.1% year-over-year revenue increase to $330 million, driven by consistent performance across its core and developing markets.

Key takeaways

Net income of $13 million alongside an 11.5% rise in adjusted EBITDA to $51 million, showcasing effective capital allocation and operational efficiency.
Illinois and Montana dominate revenue streams, accounting for 82% of total revenue, with Illinois benefiting from same-store growth and new machine placements.
Significant progress in developing markets, particularly Nebraska and Georgia, which achieved double-digit revenue growth driven by location expansions.
Strengthened balance sheet with a $900 million senior secured credit facility completed; total stock repurchases for the year reached approximately $23.7 million.
Continued focus on technology enhancements and disciplined M&A strategy in a $15 billion fragmented local gaming market to drive future growth.

View recap

Axcelis Technologies, Inc.

ACLS Q3 2025

Reported: 2025-11-05

Axcelis Technologies delivered strong Q3 2025 results, with revenue of $214 million and non-GAAP earnings per share of $1.21, both surpassing expectations. The company announced a strategic merger with Veeco, aiming to create a leading player in the semiconductor equipment sector.

Key takeaways

Achieved record revenue in Customer Support & Improvement (CS&I) alongside slightly better-than-expected system sales.
Bookings declined sequentially but are expected to rebound in Q4, aided by positive customer sentiment and quoting activity.
The pending merger with Veeco is projected to enhance technological capabilities and market reach, particularly in Silicon Carbide and compound semiconductors.

View recap

Ascent Industries Co. Common Stock

ACNT Q3 2025

Reported: 2025-11-05

Ascent Industries reported a strong Q3 2025, achieving notable earnings growth with a 6% revenue increase and a 20% rise in gross profit, marking a key inflection point in its operational strategy as a pure-play specialty chemical company.

Key takeaways

Revenue reached $19.7 million, demonstrating solid sequential growth.
Gross profit margin improved to 30%, driven by disciplined cost management and pricing strategies.
Adjusted EBITDA swung to a positive margin of 7% from a modest loss in the prior quarter.
49% of new project commitments from Q2 translated into customer orders, reflecting strong market validation.
Robust pipeline growth continued with an additional $18.2 million in new selling projects added this quarter.

View recap

Koninklijke Ahold Delhaize N.V.

AD.AS Q3 2025

Reported: 2025-11-05

Ahold Delhaize reported solid performance in Q3 2025, driven by strategic advancements in its Growing Together initiative amidst challenging macroeconomic conditions. The company remains focused on executing its innovative plans, aimed at enhancing customer value and operational efficiency.

Key takeaways

Own brand sales growth surpassed overall store growth in both dollar and unit terms, highlighting effective agility in product offerings.
Significant advancements in the harmonization of assortments across 90% of categories aim to reduce supply complexity and foster growth.
Ahold Delhaize’s commitment to transparency and health initiatives reinforces customer trust, particularly through nutritional rating systems.
Ongoing community support programs, including partnerships with food banks, align with corporate responsibility goals and enhance brand loyalty.
Continued focus on innovation and competitive positioning signals potential for sustained growth into 2026 and beyond.

View recap

ADTRAN, Inc.

ADTN Q3 2025

Reported: 2025-11-05

ADTRAN Holdings reported solid Q3 2025 results with revenue reaching $279.4 million, driven by double-digit growth across all business segments and strong operational execution.

Key takeaways

Revenue growth of 47% year-over-year in Optical Networking, bolstered by new customer acquisitions and expanding European market presence.
Added 15 new optical customers and 14 customers for fiber access and Ethernet aggregation platforms during the quarter, indicating strong market traction.
The introduction of Mosaic One Clarity, an AI-driven application, aims to enhance operational efficiency and network performance by reducing trouble tickets by up to 75%.
Operating profit exceeded guidance, highlighting effective cost management and strategic alignment with market demand.
Closed a $201 million financing transaction, improving capital structure and providing financial flexibility for future growth initiatives.

View recap

agilon health, inc.

AGL Q3 2025

Reported: 2025-11-05

Agilon Health's Q3 2025 showed revenue of $1.44 billion, but continued challenges resulted in a negative medical margin of $57 million and adjusted EBITDA of negative $91 million. The company is focused on improving performance through enhanced data analytics and revisiting its guidance for 2025.

Key takeaways

Revenue for Q3 2025 reached $1.44 billion, impacted by lower-than-expected risk scores and high costs from exited markets.
The company has reinstated 2025 guidance, projecting a revenue midpoint of $5.82 billion and an adjusted EBITDA of negative $258 million.
Enhanced data pipeline now supports 80% of members with timely analytics, positioning agilon for improved forecasting and operational efficiencies.
Approximately 75% of agilon's members are expected to be in plans rated 4 stars or higher for 2026, outperforming the broader Medicare Advantage average.
The company is proactively negotiating payer contracts for 2026, focusing on improved terms and profitability, even at the potential expense of reduced membership.

View recap

American International Group, Inc.

AIG Q3 2025

Reported: 2025-11-05

AIG reported a strong third quarter for 2025, with significant increases in adjusted earnings per share and underwriting income, driven by strategic investments and solid performance across its commercial segments.

Key takeaways

Adjusted after-tax income per diluted share increased 77% year-over-year to $2.20, with adjusted after-tax income reaching $1.2 billion.
Underwriting income rose 81% year-over-year to $793 million, fueled by successful general insurance operations and continued low combined ratios.
Net premiums written in North America Commercial Insurance remained flat year-over-year but showed signs of growth when adjusted for prior year transactions; international segments exhibited better performance with strong contributions from Marine and Specialty lines.
AIG announced strategic investments involving Convex Group, Onex Corporation, and Everest Group, projected to be earnings, EPS, and ROE accretive within the first year post-closing.
Over the last three years, AIG returned $19 billion to shareholders through share repurchases and dividends, while maintaining a strong balance sheet and reducing debt by $4.5 billion.

View recap

Assurant, Inc.

AIZ Q3 2025

Reported: 2025-11-05

Assurant's Q3 2025 results reflected strong double-digit earnings growth in both Global Housing and Global Lifestyle, prompting an upward revision of the full-year earnings outlook.

Key takeaways

Achieved 13% adjusted EBITDA growth and 15% adjusted EPS growth year-to-date, excluding reportable catastrophes.
Increased full-year adjusted EPS growth forecast to low double digits and adjusted EBITDA growth to nearly 10%, exceeding initial expectations.
Expanded capabilities in Global Lifestyle, including a multiyear logistics agreement with a leading U.S. mobile carrier and a partnership with Best Buy for extended service contracts.
Continued momentum in Global Auto, with 4% year-to-date adjusted EBITDA growth and stable earnings from renewed partnerships with U.S. dealership groups and international OEMs.
Recognized by TIME as one of the world's best companies for the third consecutive year, underscoring commitment to client and policyholder success.

View recap

Advanced Micro Devices, Inc.

AMD Q3 2025

Reported: 2025-11-05

AMD achieved record revenue of $9.2 billion in Q3 2025, reflecting a robust 36% year-over-year growth driven by strong demand across its data center, AI, and PC segments.

Key takeaways

Data center segment revenue surged 22% year-over-year to a record $4.3 billion, bolstered by strong EPYC and Instinct processor sales.
Free cash flow more than tripled, highlighting robust financial health and efficient capital management.
AMD's EPYC processors captured significant market share, with large hyperscalers launching over 160 EPYC-powered cloud instances, marking a nearly 50% increase in availability.
The company is poised for future growth with the upcoming launch of next-generation 2-nanometer Venice processors in 2026, which show strong customer demand.
Continued expansion in the AI segment, with significant success in deploying MI350 Series GPUs across leading cloud providers, positioning AMD for robust long-term growth in AI applications.

View recap

Arista Networks, Inc.

ANET Q3 2025

Reported: 2025-11-05

Arista Networks reported strong Q3 2025 results with nearly $2.31 billion in revenue, marking the 19th consecutive quarter of growth, driven by robust demand in AI and cloud networking solutions.

Key takeaways

Revenue increased, with software and services contributing approximately 18.7% of total earnings.
Non-GAAP gross margin improved to 65.2%, supported by favorable product mix and inventory efficiencies.
The company is on track to reach $2.75 billion towards its new $10.65 billion revenue target for 2026, anticipating 20% growth.
Continued emphasis on strategic partnerships with major AI firms, enhancing their networking infrastructure for large-scale AI deployments.
Leadership changes, including the promotion of Ken Duda to President and CTO, underline a strong focus on innovation and customer engagement in AI networking.

View recap

Ares Management Corporation

ARES Q3 2025

Reported: 2025-11-05

Ares Management Corporation delivered a robust third quarter in 2025, achieving significant growth across its investment strategies, with record fundraising and strong operational metrics.

Key takeaways

Management fees increased by 28% year-over-year, while fee-related earnings (FRE) grew by 39%.
Raised a record $30 billion in new capital during the quarter, contributing to a total of over $105 billion raised in the last 12 months.
Assets Under Management (AUM) reached $595 billion, with fee-paying AUM at $368 billion, both up 28% year-over-year.
Ares closed its third infrastructure secondaries fund at $3.3 billion, making it one of the largest in the market, alongside significant momentum in the infrastructure debt sector.
Low realized loss rates in direct lending strategy remain consistent with a cumulative annual average of just 1 basis point over the past two decades.

View recap

Ardmore Shipping Corporation

ASC Q3 2025

Reported: 2025-11-05

Ardmore Shipping reported strong third-quarter results, with adjusted earnings of $12.6 million or $0.31 per share, driven by record refined product volumes and firming rates. The strategic acquisition of tankers and efficient capital allocation have further enhanced earnings power while reducing cash breakeven levels.

Key takeaways

Adjusted earnings of $12.6 million reflect strong TCE performance, with MR tankers earning $24,700 per day.
Successfully redeemed $30 million of preferred shares, reducing cash breakeven to $11,700 per day.
Continued strong demand for product tankers driven by record refined product export volumes and tight supply dynamics.
Declared a 12th consecutive dividend, consistent with capital allocation policy of returning one-third of adjusted earnings to shareholders.
Geopolitical factors and an aging fleet are creating inefficiencies, contributing positively to earnings outlook.

View recap

two

ATEN Q3 2025

Reported: 2025-11-05

A10 Networks reported a robust Q3 2025 with nearly 12% year-over-year revenue growth, driven by strong demand for AI infrastructure and cybersecurity solutions, offsetting macroeconomic headwinds.

Key takeaways

Revenue reached $74.7 million, with product revenue growing 17% and service revenue increasing by 6% year-over-year.
EBITDA margins expanded to 29.3%, up from 26.7%, indicating effective cost management amidst continued R&D investment.
The Americas region saw a remarkable 25% revenue increase on a trailing 12-month basis, underscoring significant enterprise spending on AI.
Leadership transition to CFO Michelle Caron is expected to enhance financial discipline and support strategic growth initiatives.
Full-year growth rate is projected to be around 10%, reflecting confidence in A10's positioning within the AI and cybersecurity markets.

View recap

Astronics Corporation

ATRO Q3 2025

Reported: 2025-11-05

Astronics Corporation reported robust third-quarter results with revenue reaching $211.4 million, reflecting strong demand and operational efficiencies. The company also marked significant improvements in margins and completed strategic acquisitions that enhance its competitive position.

Key takeaways

Revenue of $211.4 million represents the second highest quarterly level in company history, driven by broad-based demand and supply chain efficiency.
Operating margin improved to 10.9%, up from 4.1% a year ago, with Aerospace segment margins exceeding 16%.
Total bookings of $210 million resulted in a stable book-to-bill ratio of 1.0, with a solid backlog of $647 million.
Completed acquisitions of Envoy Aerospace and Bühler Motor Aviation are expected to enhance capabilities and generate additional revenues in 2026.
Successful refinancing actions notably reduced the cost of debt and potential future dilution, improving overall financial flexibility.

View recap

Axon Enterprise, Inc.

AXON Q3 2025

Reported: 2025-11-05

Axon reported strong Q3 2025 results, driven by significant operational efficiency improvements and strategic expansions into AI-enabled voice communications, positioning the company for continued growth.

Key takeaways

Introduction of the Prepared AI capabilities led to a 33% reduction in calls needing human operators during peak periods.
Acquisition of Carbyne enhances cloud infrastructure for call centers, promising major cost reductions and modernization for agencies.
Continued expansion into enterprise markets with the launch of the ABW Mini body camera aims to replicate public safety success globally.
Focus on interconnectivity between products strengthens Axon’s ecosystem and positions the company for future technological advancements.

View recap

Axsome Therapeutics, Inc.

AXSM Q3 2025

Reported: 2025-11-05

Axsome Therapeutics reported robust Q3 2025 results, with total revenue rising 63% year-over-year to $171 million, driven by strong demand for AUVELITY and steady growth of SUNOSI.

Key takeaways

AUVELITY sales reached $136.1 million, a 69% increase year-over-year, reflecting strong market traction.
SUNOSI revenues grew 35% year-over-year to $32.8 million, demonstrating ongoing commercial momentum.
Axsome submitted a supplemental NDA for AXS-05 in Alzheimer's disease agitation and plans to initiate multiple Phase III trials across ADHD and narcolepsy.
The company is well-positioned with a deep late-stage pipeline and a diverse portfolio of therapies addressing significant unmet needs in CNS health.

View recap

Ball Corporation Common Stock

BALL Q3 2025

Reported: 2025-11-05

Ball Corporation delivered solid third-quarter results with a 4.2% increase in beverage can volumes and a 12.1% rise in comparable diluted earnings per share, underscoring the strength of its portfolio amid market challenges.

Key takeaways

Comparable net earnings reached $277 million, supported by volume growth and effective cost management.
North America experienced a 3.5% increase in comparable operating earnings, driven by robust demand in energy drinks and nonalcoholic beverages.
EMEA segment operating earnings surged by 14.8%, reflecting continued strong volume growth and favorable demand trends.
The company expects 12% to 15% growth in comparable diluted earnings per share for 2025 and anticipates ending the year with volume growth above the long-term 2% to 3% range.

View recap

BB Seguridade Participacoes S.A.

BBSEY Q3 2025

Reported: 2025-11-05

BB Seguridade reported a record third-quarter recurring net income of BRL 2.6 billion, marking a 13.1% year-on-year increase, driven by exceptional investment income and effective cost management.

Key takeaways

Investment income surged by 55% year-on-year, contributing significantly to the bottom line.
The company achieved a year-to-date recurring profit of BRL 6.8 billion, reflecting an almost 14% increase compared to the previous year.
Customer-centric initiatives led to a 5.1-point rise in Net Promoter Score (NPS) and a 24% reduction in complaints.
New credit life insurance products for small and medium-sized businesses generated BRL 294 million in premiums within three months of launch.
Loss ratios remained strong across all lines, emphasizing the quality of risk management.

View recap

BioCryst Pharmaceuticals, Inc.

BCRX Q3 2025

Reported: 2025-11-05

BioCryst reported a robust Q3 2025, driven by strong revenue growth for ORLADEYO, strategic divestitures, and a clean balance sheet, setting the stage for future expansion.

Key takeaways

ORLADEYO revenue guidance raised to $590-$600 million for 2025, even amid increased competition.
Successful divestiture of European operations and debt payoff, resulting in an operating profit and positive cash flow.
Encouraging early data expected from the BCX17725 study for Netherton syndrome, with patient enrollment slightly delayed.
Anticipating the acquisition of Astria to enhance the pipeline with navenibart, targeting expanded HAE treatment options.
New prescriptions for ORLADEYO exceeded prior year totals, reflecting continued strong market demand and physician trust.

View recap

Bunge Limited

BG Q3 2025

Reported: 2025-11-05

Bunge's Q3 2025 results show resilience and growth in its soybean and softseed processing segments, enhanced by the integration of Viterra, despite challenges in refining operations.

Key takeaways

Adjusted EPS of $2.27 slightly decreased year-over-year, reflecting competitive market pressures and integration costs from the Viterra acquisition.
Adjusted EBIT surged to $924 million, up from $559 million, driven by improved margins in soybean processing globally and synergies from expanded operations.
Operational efficiencies revealed through enhanced information sharing across the newly combined company are expected to unlock long-term value for stakeholders.
Full-year adjusted EPS guidance remains robust at $7.30 to $7.60, indicating confidence in the company’s ongoing operational integration and market strategies.

View recap

TopBuild Corp.

BLD Q3 2025

Reported: 2025-11-05

TopBuild reported solid third-quarter results, achieving 1.4% sales growth to $1.4 billion, driven mainly by strategic acquisitions despite a challenging macro environment.

Key takeaways

Acquired Progressive Roofing and several other companies, building a strong platform for growth in the commercial roofing sector with projected annual run-rate synergies of $35-$40 million over the next two years.
Adjusted EBITDA margin held steady at 19.8%, reflecting continued operational excellence and focus on profitability.
Sales growth driven by M&A contributions of 7.9%, however, volume declined by 6.7% due to weaker residential market conditions.

View recap

BioNTech SE

BNTX Q3 2025

Reported: 2025-11-05

BioNTech posted significant advancements in its oncology pipeline during Q3 2025, reinforcing its position as a leader in immunotherapy development with promising updates on both Pumitamig and mRNA cancer therapies.

Key takeaways

Progress in two global registrational trials for Pumitamig, targeting lung cancer, with Phase III initiation planned for TNBC before year-end.
Positive Phase II updates for BNT111 and Autogene cevumeran highlight the potential of mRNA therapies in low tumor burden settings, emphasizing their role in early intervention.
Successful launch of a variant-adapted COVID-19 vaccine, with a strong financial position of over EUR 16 billion in cash and equivalents, supporting ongoing oncology initiatives.
Integration of AI technologies showcased during the second AI Day, enhancing personalized therapy development and addressing treatment variability.
Continued evaluation of novel combinations, including a trial for TPAM with Pumitamig, aiming for regulatory submissions and data updates by 2026.

View recap

BP p.l.c.

BP Q3 2025

Reported: 2025-11-05

BP delivered solid third-quarter results, achieving underlying pretax earnings of $5.3 billion and generating $7.8 billion in operating cash flow, continuing to make progress toward its long-term growth targets.

Key takeaways

Underlying net income reached $2.2 billion, supporting adjusted free cash flow growth target of 20% CAGR through 2027.
Upstream production increased by 3% quarter-on-quarter, leading to upgraded full-year production guidance.
The company initiated six major projects in 2025, with four ahead of schedule, and made 12 exploration discoveries, notably the promising Bumerangue project in Brazil.
Operating cash flow robust at $7.8 billion, with a disciplined capital investment approach keeping organic CapEx below $14 billion.
Ongoing strategic review of portfolio, including Castrol, with strong interest from potential buyers for upcoming divestments to support balance sheet strength.

View recap

BP p.l.c.

BP.L Q3 2025

Reported: 2025-11-05

BP's Q3 2025 results showcased strong operational performance, with underlying pre-tax earnings hitting $5.3 billion and solid cash flow generation, reinforcing the company's growth trajectory.

Key takeaways

Underlying net income reached $2.2 billion with $7.8 billion in operating cash flow, supporting a 20% CAGR growth target for adjusted free cash flow from 2025 to 2027.
Upstream production increased by 3% quarter-on-quarter, maintaining plant reliability at approximately 97%.
Six new major oil and gas projects commenced in 2025, with four ahead of schedule, contributing to 12 exploration discoveries year-to-date.
Refining margins improved, leading to an approximate 40% increase in underlying earnings in the first nine months compared to the prior year.
BP is on track with its strategic divestment plan, having completed or announced $5 billion in proceeds toward a $20 billion target.

View recap

Bruker Corporation

BRKR Q3 2025

Reported: 2025-11-05

Bruker Corporation reported third-quarter 2025 revenues of $860.5 million, a slight decrease year-over-year but showing sequential improvement in organic bookings, particularly in the biopharma sector.

Key takeaways

Organic bookings grew mid-single digits, with high teen percentage growth in government and academic markets, signaling a potential turnaround.
Third-quarter non-GAAP operating margin improved sequentially to 12.3%, from 9.0% in Q2 2025, despite lower year-over-year revenue absorption.
Currency fluctuations contributed a 2.9% tailwind; however, organic revenue declined 4.5% year-over-year, indicating ongoing challenges in the scientific instruments segment.
Cost savings initiatives are on track to meet goals of $100 million to $120 million, expected to bolster margins and EPS growth in 2026.

View recap

CareDx, Inc

CDNA Q3 2025

Reported: 2025-11-05

CareDx reported robust third-quarter 2025 results with total revenue reaching $100.1 million, marking a 21% year-over-year growth, driven by strong performance across its testing services and product offerings.

Key takeaways

Testing Services revenue reached $72.2 million, a 19% increase year-over-year, with a total of approximately 50,300 tests delivered.
Adjusted EBITDA surged to $15.3 million, more than doubling from the same quarter last year.
The company has raised its 2025 revenue guidance to $372-$376 million and adjusted EBITDA guidance to $35-$39 million.
CareDx announced the launch of HistoMap Kidney, a breakthrough tissue-based molecular test aimed at improving diagnostic precision in transplant care.
Share repurchases accelerated, with 2 million shares bought back at an average price of $12.87, totaling approximately 9% repurchased year-to-date.

View recap

Cipher Mining Inc. Common Stock

CIFR Q3 2025

Reported: 2025-11-05

Cipher Mining reported a transformative third quarter, highlighted by key partnerships with Google and Amazon Web Services, establishing the company as a leading high-performance computing (HPC) data center developer.

Key takeaways

Secured a 15-year lease with Amazon Web Services, guaranteeing $5.5 billion in contract revenue through a 300-megawatt capacity.
Expanded development pipeline with a joint venture on a 1-gigawatt HPC site in West Texas, demonstrating strong sourcing capabilities and market demand.
Initial deal with Google and Fluidstack generating $3 billion in revenue over 10 years, with potential expansion to $7 billion over 20 years.
Construction is underway at Barber Lake site, with delivery of critical IT capacity expected by September 2026.
Anticipates financing construction primarily through debt, mitigating the need for additional equity fundraising.

View recap

Clean Energy Fuels Corp.

CLNE Q3 2025

Reported: 2025-11-05

Clean Energy Fuels reported solid Q3 2025 results, achieving $106 million in revenue and $17 million in adjusted EBITDA, while reaffirming its strong financial outlook for the year.

Key takeaways

Revenue increased to $106 million, driven by the sale of 61 million gallons of renewable natural gas (RNG).
Adjusted EBITDA stood at $17 million, in line with management's raised guidance for 2025.
Clean Energy secured contracts for hydrogen fueling stations, expanding its long-term partnerships and supporting the transition towards cleaner fuels.
The company is strategically tapping into the heavy-duty trucking sector, emphasizing RNG's cost advantages and environmental benefits over diesel.
Initial operations began at two major dairy RNG projects, enhancing Clean Energy's production capacity and sustainability profile.

View recap

COMPASS Pathways plc

CMPS Q3 2025

Reported: 2025-11-05

COMPASS Pathways reported significant progress in its Phase III trials for COMP360, with an accelerated NDA filing timeline now targeted for Q1 2026, positioning the company for potential market entry into treatment-resistant depression (TRD).

Key takeaways

The completion of enrollment in the COMP006 trial enhances clarity for data readouts and regulatory timelines.
Positive discussions with the FDA support a rolling NDA submission strategy and a potential accelerated launch.
Cash reserves stand at $186 million, providing a runway into 2027, with disciplined spending amid ongoing operational expenditures.
Ongoing preparations for commercial launch leverage insights from provider dynamics and patient preferences, aiming for effective integration into expanding psychiatric treatment infrastructure.

View recap

Compass, Inc.

COMP Q3 2025

Reported: 2025-11-05

Compass, Inc. reported record third-quarter results, achieving significant increases in revenue, adjusted EBITDA, and market share despite ongoing challenges in the housing market.

Key takeaways

Revenue grew 23.6% year-over-year, reaching the high end of guidance.
Adjusted EBITDA surged 80% to $93.6 million, exceeding expectations by 17%.
Added a record 851 gross principal agents, with a strong retention rate of 97.3%.
Total transactions increased 22%, significantly outpacing industry growth.
Company remains on track to deliver $50 million to $75 million in adjusted EBITDA improvements by 2026, bolstered by the anticipated merger with Anywhere Real Estate.

View recap

Cumberland Pharmaceuticals Inc.

CPIX Q3 2025

Reported: 2025-11-05

Cumberland Pharmaceuticals reported solid financial performance in Q3 2025, marked by strategic commercial partnerships and a focus on expanding its product portfolio. The company's revenue growth and continued operational advancements reinforce optimistic future projections.

Key takeaways

Entered a joint commercialization agreement with RedHill Biopharma for Talicia, now a first-line therapy for H. pylori infections; projected 2024 net sales of $8 million.
Third quarter revenues reached $8.3 million, with a 12% increase year-to-date despite shipment delays.
Positive cash flow from operations of nearly $5 million year-to-date, indicating robust financial health amid ongoing investments.

View recap

Coupang, Inc.

CPNG Q3 2025

Reported: 2025-11-05

Coupang's Q3 2025 results show a solid revenue growth of 18% year-over-year, alongside improved margins, reflecting the company's strong positioning in the Korean market and effective operational strategies.

Key takeaways

Consolidated revenues reached $9.3 billion, up 18% year-over-year, with a 20% increase on a constant currency basis.
Gross profit margins expanded over 50 basis points to 29.4%, while adjusted EBITDA margins improved by 10 basis points to 4.5%.
Active customer growth of 10% underpinned strong spending across existing customer cohorts.
Significant investments in first-party offerings and last-mile logistics in Taiwan are set to enhance future growth.
Ongoing deployment of automation technologies is expected to drive further efficiency and operating cost reductions.

View recap

Corebridge Financial, Inc.

CRBG Q3 2025

Reported: 2025-11-05

Corebridge Financial reported solid Q3 2025 results, achieving record sales while strengthening its balance sheet and maintaining high capital efficiency. The company also navigated significant management changes effectively.

Key takeaways

Total premiums and deposits reached $12.3 billion, driven by a strong performance in Individual Retirement and Institutional Markets.
Corebridge received regulatory approval to sell its registered index-linked annuity (RILA) product in New York, expanding its market footprint.
The company completed a significant variable annuity reinsurance transaction, enhancing capital efficiency and liquidity.
Year-to-date capital returns to shareholders exceeded $1.4 billion through buybacks and dividends, with an 80% payout ratio.
The completion of a voluntary early retirement program aims to modernize operations and improve customer experiences.

View recap

Cricut, Inc.

CRCT Q3 2025

Reported: 2025-11-05

Cricut reported solid Q3 2025 results with a 2% sales growth accompanied by a remarkable 114% increase in operating income, marking its second consecutive quarter of positive year-on-year revenue growth.

Key takeaways

Operating income surged 114% year-on-year, while EPS doubled, reflecting strong cost management.
Paid subscribers grew by 6%, reaching over 3 million, driven by effective marketing and promotional strategies.
Engagement metrics showed early signs of recovery, with overall marketing engagement increasing by over 20% year-on-year.
Accessory and material sales declined 17%, highlighting ongoing competitive pressures in this segment.
Continued focus on user acquisition and engagement is expected to drive future growth, supported by recent product innovations and AI-driven enhancements.

View recap

Comstock Resources, Inc.

CRK Q3 2025

Reported: 2025-11-05

Comstock Resources delivered strong Q3 results, characterized by a notable increase in natural gas sales to $335 million, driven by heightened demand and strategic divestitures aimed at bolstering the company's financial position.

Key takeaways

Achieved adjusted net income of $28 million ($0.09 per diluted share), reversing losses from Q3 2024.
Production averaged 1.22 Bcfe/day, with new wells contributing to future growth in the Western Haynesville area.
Completed the sale of nonstrategic assets, including Cotton Valley wells for $15.2 million and pending divestiture of Shelby Trough properties for $430 million.
EBITDAX for the quarter reached $249 million, reflecting strong operational efficiency and higher commodity prices.
Continued focus on drilling efficiency, with costs averaging $1,229 per lateral foot, positioning Comstock competitively in the basin.

View recap

Corsair Gaming, Inc.

CRSR Q3 2025

Reported: 2025-11-05

Corsair Gaming reported a robust Q3 2025 with net revenue rising 14% year-over-year to $345.8 million, alongside significant profit expansion driven by strong consumer acceptance of innovative products.

Key takeaways

Double-digit revenue growth was supported by strong demand in the Components and Systems segment, particularly for high-performance gaming products.
Gross profit increased 33.6% to $93.1 million, with gross margin improving by 400 basis points to 26.9% due to a favorable product mix.
European markets accounted for 40% of total revenues, underscoring strong international performance.
The company is well-positioned for future growth in the Sim Sports segment and plans to leverage its AI roadmap for further innovation.
Corsair continues to manage operating expenses effectively while investing in strategic long-term initiatives.

View recap

CT Real Estate Investment Trust

CRT-UN.TO Q3 2025

Reported: 2025-11-05

CT REIT reported strong Q3 2025 financial results, highlighted by a 5.5% increase in net operating income and a solid occupancy rate of 99.4%. The strategic acquisition of a Canadian Tire-anchored property in Calgary and successful redevelopment activities underpin continued growth momentum.

Key takeaways

Net operating income grew by 5.5%, driven by acquisitions and leasing activity.
AFFO per unit increased by 2.9%, demonstrating robust financial health.
Strong investment pipeline with over $427 million committed across 20 projects, adding more than 1 million square feet of GLA.
Occupancy rate remains impressive at 99.4%, with a weighted average lease term of 7.3 years.
New acquisitions and redevelopments are projected to yield attractive returns, enhancing long-term growth prospects.

View recap

Coterra Energy Inc. Common Stock

CTRA Q3 2025

Reported: 2025-11-05

Coterra Energy delivered strong third-quarter results with production exceeding guidance, solidifying its commitment to profitable growth and enhancing shareholder value amidst a dynamic market landscape.

Key takeaways

Production across oil, natural gas, and BOE exceeded guidance by approximately 2.5%, with NGL production reaching an all-time high.
Successful integration of Lea County assets has led to improved performance and cost reductions, enhancing future inventory prospects.
Management remains disciplined regarding capital expenditures, focusing on consistent free cash flow and profitability while monitoring market dynamics closely.

View recap

Corteva, Inc.

CTVA Q3 2025

Reported: 2025-11-05

Corteva Agriscience reported strong third-quarter results characterized by double-digit EBITDA growth, driven by robust performance in both its Seed and Crop Protection segments, alongside a proactive strategy to separate into two public companies.

Key takeaways

Third-quarter operating EBITDA rose by 14% year-over-year, with the company raising its full-year EBITDA guidance to a range of $3.8 billion to $3.9 billion.
The Seed business achieved $200 million in productivity benefits and is on track to achieve double-digit trade penetration for Conkesta in Brazil.
The Crop Protection segment anticipates high single-digit EBITDA growth for the year, supported by demand for differentiated technologies and the launch of the new insecticide Varpelgo.
Corteva expects to deliver over $600 million in controllable benefits for 2025, up from a prior estimate of $530 million.
The planned separation into two public companies is expected to enhance growth potential for the Seed and Crop Protection units, with a target completion set for the second half of 2026.

View recap

Crexendo, Inc.

CXDO Q3 2025

Reported: 2025-11-05

Crexendo reported impressive Q3 2025 results, with a 12% year-over-year revenue increase and solid profitability, demonstrating the efficacy of its growth strategy and AI-driven innovations.

Key takeaways

Revenue reached $1.5 million in GAAP net income and $3 million in non-GAAP net income.
Software solutions revenue surged by 28%, signalling strong demand for Crexendo’s offerings.
Customer satisfaction is reinforced by #1 rankings in 18 categories by G2, emphasizing exceptional service in the SMB market.
Over 7 million end users have adopted the platform, highlighting substantial scalability and market penetration.
Continued investments in AI and next-gen solutions position Crexendo for sustained growth and competitive advantage.

View recap

Dave Inc. Class A Common Stock

DAVE Q3 2025

Reported: 2025-11-05

Dave reported a record third quarter, achieving a 63% year-over-year revenue increase to $150.8 million, alongside a robust adjusted EBITDA of $58.7 million, reinforcing its strategic focus on maximizing gross profit.

Key takeaways

Monthly transacting members grew 17% year-over-year to 2.77 million, reflecting strong customer engagement.
CashAI v5.5 rollout delivered improved credit performance, boosting ExtraCash originations by 49% year-over-year.
New pricing models have enhanced net monetization rates, resulting in better portfolio spreads and member lifetime value.
High-margin subscription revenue rose 57% year-over-year, with a $3 monthly fee for new members contributing significantly to profitability.
Cost to acquire new members remained stable, while payback periods improved to under 4 months, indicating efficient growth strategies.

View recap

Delcath Systems, Inc.

DCTH Q3 2025

Reported: 2025-11-05

Delcath Systems reported a mixed third quarter in 2025, with a notable impact from 340B pricing adjustments and seasonality affecting new patient starts, prompting a revised revenue guidance. However, positive clinical results from the CHOPIN trial highlight the potential for future growth.

Key takeaways

Revenue guidance for 2025 adjusted to $83M-$85M due to slower new patient starts and 340B pricing effects, resulting in a 13% decrease in average revenue per kit.
Four new treatment sites activated recently, increasing total to 25 REMS-certified centers, with a target of 26-28 centers by the end of 2025.
Strong clinical trial data from the CHOPIN trial reported at ESMO, showing significant improvements in progression-free survival and overall response rates, positioning HEPZATO as a key therapy for uveal melanoma.
Competition from various clinical trials noted as a factor in slower patient initiation, though the CHOPIN trial’s compelling results may mitigate this challenge.
Plans to expand the U.S. sales force further by 2026 to enhance site activation and referral networks to aid growth.

View recap

Eastman Chemical Company

EMN Q3 2025

Reported: 2025-11-05

Eastman reported a challenging Q3 2025 with lower volumes and significant cost pressures, yet remains optimistic about future growth driven by cost reductions and innovative product launches.

Key takeaways

Full-year EBIT expected to decrease due to a 4% drop in Advanced Materials and a 2% drop in AFP, exacerbated by trade disputes and inventory adjustments.
Targeting $100 million in cost reductions for 2026, building on the $75 million achieved this year.
Anticipating a revenue boost from innovative products, particularly in the circular polyester methanolysis sector and automotive-related applications.
Focused on maintaining stable pricing and cash flow amidst slight pricing declines, with an emphasis on commercial excellence and market share recovery.
Projected volume growth in 2026 hinges on improved utilization rates and stabilization of demand volatility.

View recap

Emerson Electric Co.

EMR Q4 2025

Reported: 2025-11-05

Emerson reported solid fourth-quarter results, with underlying sales up 4% and a notable increase in profitability, yet full-year growth fell slightly short of expectations due to softness in Europe and China.

Key takeaways

Fourth-quarter underlying orders grew 6%, driven by a robust 27% increase in Test & Measurement segment.
Adjusted earnings per share reached $1.62 for the quarter, at the upper end of guidance; full-year adjusted EPS increased by 9%.
The company expects 5.5% sales growth for fiscal 2026, with adjusted EPS projected between $6.35 and $6.55.
Free cash flow improved to $3.24 billion, up 12% year-over-year, supporting robust capital return plans of $2.2 billion to shareholders.
Emerson's annual contract value from software grew 10%, highlighting sustained investment in digital transformation.

View recap

Enel Chile S.A.

ENIC Q3 2025

Reported: 2025-11-05

Enel Chile delivered stable EBITDA for the first nine months of 2025, successfully mitigating hydrological challenges through a strong thermal generation performance and strategic gas utilization.

Key takeaways

EBITDA held steady year-over-year despite a difficult hydrological context, reflecting operational resilience.
Recovery of $261 million in receivables bolstered cash flow, enhancing liquidity and capacity to support development plans.
Successful execution of a winter plan improved grid resilience and service continuity, particularly for vulnerable customers.
Thermal production was up, offsetting a 9% decrease in net production driven by lower hydro dispatch and renewable energy maintenance.
Contracted gas sales to Europe helped maintain margins amidst market volatility, with ongoing evaluations for securing competitive gas in 2026.

View recap

The Ensign Group, Inc.

ENSG Q3 2025

Reported: 2025-11-05

The Ensign Group reported a record quarter in Q3 2025, driven by strong clinical performance and growing occupancy rates, setting the stage for sustained long-term growth.

Key takeaways

Same-store occupancy reached all-time highs of 83% and 84.4%, reflecting increased market share and trust from communities served.
Medicare revenue increased by 10% for same-store operations, highlighting improved skilled mix and demand for services.
The aged 80+ population in the U.S. is expected to grow over 50% by 2035, providing a significant demographic tailwind for skilled nursing services.
Operational efficiencies led to 5.1% and 10.9% increases in skilled days for same-store and transitioning operations, respectively.
Continued acquisition of new operations is expected to unlock additional long-term value across the portfolio.

View recap

Eaton Corporation plc

ETN Q3 2025

Reported: 2025-11-05

Eaton reported a strong third quarter of 2025, with robust demand across its Electrical Americas and Aerospace segments, leading to record backlog levels and an 8% year-over-year increase in adjusted earnings per share.

Key takeaways

Electrical Americas orders grew 7% year-over-year, with backlog up 20%, reaching an all-time high.
Aerospace segment saw 11% order growth with a backlog increase of 15%.
Adjusted earnings per share rose 8%, and segment margins improved to a quarterly record of 25%.
The company announced the acquisition of Boyd's thermal business, a key move to enhance its liquid cooling solutions for data centers.
Reaffirmation of 2025 guidance underlines the firm’s commitment to sustained growth and value creation.

View recap

Entravision Communications Corporation

EVC Q3 2025

Reported: 2025-11-05

Entravision's 3Q 2025 revenue increased by 24% to $120.6 million, driven primarily by growth in its Advertising Technology & Services (ATS) segment, despite an operating loss of $9 million attributed to restructuring costs and declining Media revenues.

Key takeaways

Media segment revenue fell 26% year-over-year to $44.5 million, impacted by lower political advertising and ongoing challenges in local markets.
ATS segment revenue surged 104% to $76.1 million, reflecting strong customer growth and improved revenue per account, with a sequential growth of 38%.
Operating expenses rose significantly due to investments in sales capacity and technology for both Media and ATS segments, leading to an overall operating loss despite breakeven results excluding exceptional charges.
The company is focused on enhancing local sales capabilities and expanding digital operations to improve overall profitability moving forward.

View recap

Vertical Aerospace Ltd.

EVTL Q3 2025

Reported: 2025-11-05

Vertical Aerospace showcased strong progress in its flight testing and certification journey during the third quarter, positioning itself as a leader in the eVTOL market with unique, spacious aircraft designs.

Key takeaways

Successfully initiated the critical final phase of flight testing under UK CAA oversight, with 11 planned test flights.
Achieved design organization approval in 2023 and maintained over 3,500 hours of CAA regulatory review, reinforcing confidence in a 2028 certification timeline.
VX4 aircraft offers the most spacious cabin in the industry, allowing for a potential 50% increase in operator revenue by accommodating up to 6 passengers.

View recap

Exelixis, Inc.

EXEL Q3 2025

Reported: 2025-11-05

Exelixis delivered strong third-quarter results, characterized by robust revenue growth driven by the success of cabozantinib and early achievements for zanzalintinib, setting the stage for future growth.

Key takeaways

Cabozantinib U.S. net product revenues rose 14% year-over-year to $543 million, maintaining its leadership in the TKI market for renal cell carcinoma (RCC).
Global cabozantinib revenues reached approximately $739 million, bolstered by a 50% increase in demand within the neuroendocrine tumor (NET) segment.
Zanzalintinib is gaining momentum with seven pivotal trials underway; recent positive results in colorectal cancer (CRC) suggest potential regulatory submissions soon.
The expansion of the GI sales team aims to accelerate growth in the CABINET indication, enhancing the company’s commercial footprint.
Exelixis is committed to a disciplined capital allocation strategy while progressing its diverse R&D pipeline for sustained long-term value creation.

View recap

Diamondback Energy, Inc.

FANG Q3 2025

Reported: 2025-11-05

Diamondback Energy delivered a solid Q3 2025 performance, emphasizing capital discipline with a strategic focus on free cash flow generation amid fluctuating market conditions.

Key takeaways

Achieved a year-to-date reinvestment rate of 36% at mid-60s oil prices, prioritizing free cash flow per share.
Q4 capital expenditures projected at $925 million, with production expected to stabilize at approximately 505,000 barrels per day.
Continued emphasis on cost structure improvements and well performance, highlighted by a successful shift to co-development strategies in the Midland Basin.
The merger with Endeavor is expected to yield enhanced well productivity and overall returns in the coming years.

View recap

Fidelity National Information Services, Inc.

FIS Q3 2025

Reported: 2025-11-05

Fidelity National Information Services (FIS) demonstrated robust performance in Q3 2025, with adjusted revenue growth of 6.3% and adjusted EPS rising 8% year-over-year, driven by successful strategic initiatives and a strong market outlook.

Key takeaways

Achieved adjusted EBITDA margins of 41.8%, reflecting improved segment profitability in Banking and Capital Markets.
Increased share repurchase target to $1.3 billion for the year, with $509 million returned to shareholders in Q3.
Recurring revenue growth of 6.4% indicates strong adoption of commercial excellence initiatives, supported by robust bank technology spending.
AI integration is accelerating, with over 75% of banks actively piloting AI solutions, presenting FIS with significant growth opportunities.
Expectations of continued industry consolidation will bolster FIS’s position as a preferred partner for scalable financial services technology.

View recap

Flywire Corporation

FLYW Q3 2025

Reported: 2025-11-05

Flywire delivered a strong performance in Q3 2025, driven by significant client acquisitions and robust revenue growth, highlighting its effective diversification strategy across verticals.

Key takeaways

Successfully signed over 200 new clients, indicating strong execution and demand across education, travel, and healthcare verticals.
The Student Financial Software platform was a key growth driver, aiding institutions in recovering $360 million in past due tuition.
Significant progress in international markets, with over half of new education wins coming from outside traditional markets.
Product innovation, including AI-driven enhancements, continues to support operational efficiencies and improve client experiences.
Strong momentum in the travel vertical, bolstered by integration synergies from the Sertifi acquisition, contributing to overall revenue growth.

View recap

Franco-Nevada Corporation

FNV Q3 2025

Reported: 2025-11-05

Franco-Nevada Corporation reported record financial results for Q3 2025, driven by significant increases in gold and silver prices, strategic acquisitions, and robust operational performance.

Key takeaways

Total revenue surged 77% year-over-year to $487.7 million, with precious metals comprising 85% of total revenue.
Total GEOs sold increased by 26% to 138,772, reflecting a 41% rise in precious metal GEOs compared to Q3 2024.
Acquisitions of key gold assets, including Porcupine, Yanacocha, and Côté, are contributing to expected 50% growth in GEOs over the next five years.
Strong operational performance noted at Cobre Panama, with completion of concentrate shipments and preparations underway for power plant restart.
Franco-Nevada remains debt-free, reflecting strong cash flow generation and prudent capital management following the recent acquisition investments.

View recap

Amicus Therapeutics, Inc.

FOLD Q3 2025

Reported: 2025-11-05

Amicus Therapeutics reported robust third-quarter growth in its Fabry and Pompe business, achieving double-digit revenue increases and GAAP profitability while reinforcing its confidence in reaching $1 billion in combined sales by 2028.

Key takeaways

Revenue for Galafold reached $138.3 million, representing a 12% increase at constant exchange rates and a 15% rise in reported terms.
The company experienced a 13% year-over-year patient growth for Galafold, with record demand and the highest level of new patient starts since its launch.
Pombiliti and Opfolda also showed significant momentum, contributing to strong commercial demand across established and new markets.
The ongoing Phase III ACTION3 study for DMX-200 is over 90% enrolled, addressing a critical need in FSGS treatment.
Amicus maintains a growing cash position and anticipates achieving GAAP net income for the second half of the year.

View recap

L.B. Foster Company

FSTR Q3 2025

Reported: 2025-11-05

L.B. Foster reported modest sales growth of 0.6% in Q3 2025, driven by a strong performance in the Infrastructure segment, while facing challenges in the Rail sector due to planned downsizing and delivery timing. Despite a decline in net income, operational cash flow remained robust, allowing for significant debt reduction.

Key takeaways

Infrastructure segment sales rose by 4.4%, led by a 12.7% increase in steel products.
Rail segment sales declined 2.2%, with a notable 63.9% increase in rail orders indicating growth potential.
Adjusted EBITDA decreased 7.9% year-over-year to $11.4 million, impacted by lower margins and sales mix.
Cash provided by operations reached $29.2 million, enabling net debt reduction to $55.3 million, with gross leverage improving to 1.6x.
A favorable backlog position of $247.4 million suggests strong Q4 sales growth projected at approximately 25%.

View recap

fuboTV Inc.

FUBO Q3 2025

Reported: 2025-11-05

fubo reported strong third-quarter results, highlighted by significant subscriber growth and a strategic business combination with Hulu + Live TV, positioning the company favorably for future expansion.

Key takeaways

Achieved 1.63 million paid subscribers in North America, the highest third-quarter count to date, with a notable 1.1% year-over-year increase.
Total revenue of $368.6 million, reflecting a 2.3% decline from the previous year, attributed to prior year one-time benefits and ad revenue challenges.
Experienced a nearly 50% reduction in churn year-over-year, alongside improved trial conversion rates and reduced marketing spend in a competitive landscape.
The completion of the Hulu + Live TV merger creates one of America’s largest live TV streaming services and enhances customer offerings.
Positive momentum in advertising demand, indicated by a 36% increase in upfront commitments for the 2025-2026 cycle, with substantial engagement from new advertisers.

View recap

First Watch Restaurant Group Inc. Common Stock

FWRG Q3 2025

Reported: 2025-11-05

First Watch Restaurant Group reported a robust third-quarter performance, with total revenue soaring by 25.6% year-over-year, driven by strong same-restaurant sales growth and strategic unit expansion.

Key takeaways

Same-restaurant sales increased by 7.1%, marking the fourth consecutive quarter of growth.
Restaurant-level operating profit margin improved significantly, demonstrating effective operational execution.
The company opened 21 new locations in Q3, on track for a total of 63 to 64 new restaurants for the fiscal year, equating to nearly 11% system-wide growth.
Notably, nine of the ten highest opening week sales in history were achieved by restaurants opened within the last 12 months.
First Watch maintained a strategic pricing approach to combat inflation, prioritizing long-term growth over short-term margin protection.

View recap

Gibson Energy Inc.

GEI.TO Q3 2025

Reported: 2025-11-05

Gibson Energy reported a robust third quarter in 2025, achieving record throughput levels across multiple terminals, leading to strong operational and financial outcomes.

Key takeaways

Third quarter consolidated throughput reached a record 2.2 million barrels per day, up 27% year-over-year.
Infrastructure EBITDA was near-record at $154 million, with distributable cash flow at $86 million.
Completion of the Cactus II connection enhances supply access by 700,000 barrels per day, supporting Gateway's growth strategy.
Cost-focused initiatives are expected to yield over $25 million in savings by the end of 2025, contributing $9 million to distributable cash flow this quarter.
Strengthened leadership in U.S. market development with the appointment of Blake Hotzel, positioning the company for continued growth.

View recap

Genius Sports Limited

GENI Q3 2025

Reported: 2025-11-05

Genius Sports reported a strong Q3 2025, achieving a 38% year-on-year revenue increase and a 32% rise in adjusted EBITDA, driven primarily by significant growth in its Media segment.

Key takeaways

Revenue grew by 38% year-on-year, marking the strongest quarterly growth since Q1 2022.
Media segment revenue surged nearly 90% year-on-year to a record $42 million, exceeding prior guidance expectations.
Betting revenue increased 28% year-on-year, bolstered by exclusive rights acquisitions and expanded partnerships.
In-play betting accounted for 30% of total NFL handle during the season, indicating strong engagement trends.
The number of sportsbooks utilizing the BetVision product has grown from 6 to over 100 in just one year, reflecting significant scalability and market demand.

View recap

Graphic Packaging Holding Company

GPK Q3 2025

Reported: 2025-11-05

Graphic Packaging reported strong third-quarter results with sales of $2.2 billion and adjusted EBITDA of $383 million, highlighting continued operational efficiency despite challenging market conditions.

Key takeaways

Adjusted EBITDA margin improved to 17.5% with adjusted EPS at $0.58, indicating solid financial management.
Successfully launched commercially saleable rolled paperboard at the Waco facility ahead of schedule, enhancing competitive positioning in the recycled paperboard market.
Despite a 2% decline in volumes year-over-year, Graphic Packaging outperformed broader industry trends and remains well-positioned for growth through proprietary innovations.
Market pressures noted in grocery volumes; however, strategic investments are expected to bolster long-term profitability amidst competitive pricing challenges.

View recap

Global Payments Inc.

GPN Q3 2025

Reported: 2025-11-05

Global Payments reported strong third-quarter results, showcasing robust growth across its merchant business while advancing key strategic initiatives, including the upcoming Worldpay acquisition.

Key takeaways

Achieved 6% constant currency adjusted net revenue growth and 11% constant currency adjusted EPS growth year-over-year.
Adjusted free cash flow totaled $784 million, enabling a reduction in adjusted net leverage to 2.9x, below the targeted 3x.
Successful rollout of the Genius platform saw over 90% of sales to new customers, with monthly recurring revenue from new sales up 75% since June.
Regulatory approval for the Worldpay acquisition positions the company for a first-quarter 2026 closing, aligning with the timeline for divesting its Issuer Solutions business.
The company returned $500 million to shareholders through an accelerated share repurchase program.

View recap

The Hackett Group, Inc.

HCKT Q3 2025

Reported: 2025-11-05

The Hackett Group's third quarter results reflected stable earnings and strong innovation, highlighted by positive reception of its AI XPLR version 4 platform, although revenue slightly fell short of guidance.

Key takeaways

Revenues before reimbursements reached $72.2 million, below quarterly guidance, with adjusted earnings per share at $0.37, in line with expectations.
Strong growth in the GenAI segment, but offset by weaknesses in the OneStream practice and an expired IPaaS contract.
Strategic alliance announced with Celonis to integrate process intelligence with AI solutions, enhancing client engagement potential.
A $40 million Dutch tender offer to repurchase approximately 8% of common stock announced, anticipated to be accretive.
Continued focus on reducing headcount to leverage GenAI productivity benefits and align resources with market demands.

View recap

Hagerty, Inc.

HGTY Q3 2025

Reported: 2025-11-05

Hagerty delivered robust third-quarter results with total revenue increasing 18% year-over-year, driven by strong new business growth and an improved operating margin. Notable gains in membership and strategic partnerships position the company for continued expansion in the collectible vehicle insurance market.

Key takeaways

Total revenue reached $380 million, a significant 18% increase, fueled by a 16% rise in written premium and an impressive retention rate of 89%.
Net income surged by 73% to $121 million, supported by a 350 basis point improvement in operating margins and adjusted EBITDA growth of 46% to $153 million.
The launch of the Safe Storage Concierge service and a new partnership with Liberty Mutual enhances Hagerty's distribution capabilities and customer engagement.
Membership and marketplace revenue grew by 54%, reflecting recent international expansion efforts and the introduction of the Enthusiast Plus program.
Anticipating increased profitability, Hagerty is moving towards a 100% control of premium and risk management in collaboration with Markel, set to commence in 2026.

View recap

Hippo Holdings Inc.

HIPO Q3 2025

Reported: 2025-11-05

Hippo demonstrated robust growth in Q3 2025, achieving an adjusted net income of $18 million and a 33% increase in gross written premiums year-over-year, reinforcing its commitment to diversified and profitable growth.

Key takeaways

Secured 6 new programs in Q3, expanding the total to 36, enhancing premium diversification across commercial and casualty lines.
Improved underwriting results with net loss ratio down 25 percentage points to 48% and net combined ratio improved by 28 percentage points to 100%.
Integration with Baldwin's Westwood Insurance agency has begun, expected to triple access to new home closings, enhancing geographic presence.
Strengthened leadership with the appointment of a Chief Data Officer and new Board members, bolstering talent in key areas of risk management and corporate governance.

View recap

Harley-Davidson, Inc.

HOG Q3 2025

Reported: 2025-11-05

Harley-Davidson reported disappointing Q3 results negatively impacted by the Motor Company's performance, while the HDFS strategic transaction showcased significant long-term value.

Key takeaways

Q3 results underperformed expectations due to challenges in motorcycle inventory management and dealer profitability.
Strategic initiatives announced include improving inventory levels, introducing customer-facing promotions, and reassessing e-commerce approaches to strengthen dealer relationships.
The successful HDFS transaction solidifies the company's capital-light model and enhances overall financial resilience.
CEO Artie Starrs emphasizes the importance of brand community and dealer networks as vital growth drivers moving forward.
Ongoing focus on cost and capital efficiency is deemed essential amid current economic conditions.

View recap

Harmony Biosciences Holdings, Inc.

HRMY Q3 2025

Reported: 2025-11-05

Harmony Biosciences reported a strong third quarter in 2025, achieving $239.5 million in net revenue—a 29% year-over-year increase—while raising its revenue guidance for the year.

Key takeaways

Record patient additions for WAKIX, averaging 8,100 patients, a significant increase of 500 patients this quarter.
Q3 net revenue guidance raised from $820 million to a new range of $845 million to $865 million, driven by strong commercial performance.
Robust cash generation of $106 million, increasing total cash reserves to $778 million.
Harmony is poised for future growth with ongoing development of its late-stage pipeline, including multiple upcoming catalyst events.

View recap

Heron Therapeutics, Inc.

HRTX Q3 2025

Reported: 2025-11-05

Heron Therapeutics reported a strong Q3 2025, generating net revenues of $38.2 million and achieving adjusted EBITDA of $1.5 million, highlighting significant growth in its acute care portfolio.

Key takeaways

Achieved 49% year-over-year growth in ZYNRELEF net sales, reaching $9.3 million in Q3 2025.
APONVIE sales surged 173% year-over-year, totaling $3 million, with a dedicated sales team now deployed.
Implemented successful initiatives, including the CrossLink Ignite program and the introduction of a product-specific J-code for ZYNRELEF, enhancing distributor engagement and reimbursement processes.
Continued strong performance in CINVANTI, maintaining steady demand despite competitive pressures.
Year-to-date revenues of $114.3 million, with positive momentum projected to continue into Q4 and beyond.

View recap

Humana Inc.

HUM Q3 2025

Reported: 2025-11-05

Humana delivered a solid performance in Q3 2025, maintaining its full-year EPS outlook of approximately $17 while executing effectively amid evolving market conditions.

Key takeaways

Medical cost trends are in line with expectations, supporting ongoing profitability.
Medicare new sales are trending at the high end of anticipated ranges, with improved channel mix contributing to enhanced customer lifetime value.
The company is focused on reducing voluntary attrition through stable benefit strategies and enhanced customer service, showing favorable early indicators in the AEP.
Stars performance shows operational gains, with significant year-over-year improvements expected in key metrics for bonus year '28.

View recap

Hut 8 Corp.

HUT Q3 2025

Reported: 2025-11-05

Hut 8 reported a transformative third quarter in 2025, with revenues soaring 91% year-over-year to $83.5 million, largely driven by the rapid scaling of its Bitcoin mining operations through the newly launched American Bitcoin.

Key takeaways

Net income surged to $50.6 million, a significant increase from just $0.9 million in the previous year.
Adjusted EBITDA rose to $109 million, up from $5.6 million in Q3 2024, highlighting the company's enhanced profitability.
The launch of American Bitcoin, a consolidated subsidiary, propelled growth in the Compute segment, showcasing successful synergy between Hut 8's power and digital infrastructure assets.
Hut 8's strategic focus on a power-first model positions the company advantageously amid rising demand for energy-intensive computing solutions.
A major expansion initiative across four U.S. locations is set to more than double Hut 8’s operational scale while diversifying its strategic market presence.

View recap

Hut 8 Mining Corp.

HUT.TO Q3 2025

Reported: 2025-11-05

Hut 8 reported a robust third-quarter performance with revenue soaring 91% year-over-year to $83.5 million, driven by the rapid expansion of its American Bitcoin subsidiary, which is poised to enhance synergies across its diversified platform.

Key takeaways

Net income surged to $50.6 million, up from $0.9 million a year earlier, driven by significant gains in digital assets.
Adjusted EBITDA reached $109 million, reflecting a dramatic improvement from $5.6 million in the prior year period.
The company launched a major expansion initiative across four U.S. locations, targeting an increase in utility capacity to over 1,530 megawatts, potentially doubling platform scale.
Hut 8's strategic focus on a power-first innovation model positions it uniquely in the energy-intensive Bitcoin mining and AI computing sectors, driving long-term competitive advantages.

View recap

IDEXX Laboratories, Inc.

IDXX Q3 2025

Reported: 2025-11-05

IDEXX Laboratories reported robust Q3 2025 results with a 13% rise in revenue, bolstered by strong performance in their Companion Animal Group (CAG) business despite some headwinds from clinical visit declines.

Key takeaways

Revenue increased to $1.080 billion, a 13% year-over-year jump, with organic growth at 12%.
CAG Diagnostics recurring revenues grew 10% organically, driven by a significant rise in premium instrument placements, including over 1,750 InVue Dx analyzers resulting in 71% growth in instrument revenues.
Updated full-year guidance reflects increased revenue expectations of $4.270-$4.300 billion and EPS outlook raised to $12.81-$13.01, indicating strong operational momentum despite macro challenges.

View recap

Innovative Industrial Properties, Inc.

IIPR Q3 2025

Reported: 2025-11-05

Innovative Industrial Properties reported strong strategic advances in Q3 2025, highlighted by a $105 million investment in life sciences and a new $100 million credit facility, positioning the company for diversified growth.

Key takeaways

Completed a $105 million investment in IQHQ to enhance portfolio diversification beyond cannabis.
Secured a $100 million revolving credit facility to support new investments and strengthen the balance sheet.
Win in the Illinois court case against PharmaCann expected to facilitate regaining property control by year-end.
Continued engagement in receivership proceedings for key tenants, focusing on optimizing asset value.
Positive federal sentiment towards cannabis reform could accelerate market growth and access to capital.

View recap

Iron Mountain Incorporated

IRM Q3 2025

Reported: 2025-11-05

Iron Mountain reported a robust third quarter of 2025, achieving record highs in revenue, adjusted EBITDA, and AFFO, all driven by strong demand across its diversified business segments.

Key takeaways

Revenue increased 13% to $1.8 billion, with adjusted EBITDA rising 16% to $660 million and AFFO growing 18% to $393 million.
Data center revenue surged 33% amidst a strong leasing market, with expectations of over 25% growth in 2026.
Record performance in physical storage and digital solutions contributed significantly, with the latter winning a major $714 million contract for digitization services with the Department of Treasury.
A 10% dividend increase was authorized by the Board, reflecting sustained strong performance and encouraging future cash returns to shareholders.
The asset life cycle management segment demonstrated significant growth potential, with reported revenue increasing by 65%, bolstered by strategic acquisitions and cross-selling initiatives.

View recap

Kinross Gold Corporation

K.TO Q3 2025

Reported: 2025-11-05

Kinross Gold reported robust Q3 results, producing 504,000 ounces of gold and generating record free cash flow of nearly $700 million, reflecting strong operational performance and effective cost management.

Key takeaways

Production met guidance with a cost of sales at $1,145 per ounce, yielding margins exceeding $2,300 per ounce.
Achieved record free cash flow of $687 million in Q3 and $1.7 billion year-to-date, bolstering financial stability.
Plans underway to increase capital returns to shareholders beyond the initial $650 million commitment for the year.
Strengthened balance sheet with $1.7 billion in cash and a net cash position of nearly $500 million, improving credit outlook to positive.
Continued operational success across key mines, with notable contributions from Paracatu and Tasiast; on track to meet full-year production targets.

View recap

Kinross Gold Corporation

KGC Q3 2025

Reported: 2025-11-05

Kinross Gold delivered strong third-quarter results, producing 504,000 ounces of gold at a cost of $1,145 per ounce, contributing to record free cash flow of nearly $700 million.

Key takeaways

Adjusted earnings reached $0.44 per share, supported by an average realized gold price of $3,458 per ounce, yielding margins over $2,300 per ounce.
The company's balance sheet continues to strengthen, ending Q3 with approximately $1.7 billion in cash and a net cash position of nearly $500 million.
Kinross is committed to enhancing shareholder returns, planning to exceed its initial capital return commitment of $650 million for the year through increased dividends and share repurchases.
Key assets, including Paracatu and Tasiast, performed well, significantly contributing to production goals, while operational efficiency remains on track to meet full-year guidance.
Successful project progression in Curlew, Great Bear, and Lobo-Marte positions Kinross for future growth opportunities.

View recap

Knife River Corporation

KNF Q3 2025

Reported: 2025-11-05

Knife River Corporation reported robust third-quarter results, achieving record revenues of $1.2 billion and adjusted EBITDA of $273 million, bolstered by recent acquisitions and strategic operational improvements.

Key takeaways

Adjusted EBITDA margin improved to 22.7%, reflecting successful cost management and pricing strategies despite adverse market conditions.
Record backlog positions the company for continued growth, with specific regional strengths, notably an 83% year-over-year backlog increase in the Central segment.
Strategic acquisitions, including the integration of Strata Corporation, positively impacted volume and margins, reaffirming the effectiveness of the company's competitive EDGE strategy.

View recap

Karyopharm Therapeutics Inc.

KPTI Q3 2025

Reported: 2025-11-05

Karyopharm Therapeutics reported a strong Q3 2025, with total revenue rising 13% year-over-year to $44 million, driven by solid performance from its XPOVIO product line and significant advancements in clinical development.

Key takeaways

Completed enrollment in the pivotal Phase III SENTRY trial for frontline myelofibrosis, with top-line results expected in March and potential to redefine treatment standards.
Achieved U.S. net product revenue growth of 8.5%, totaling $32 million, reflecting ongoing strength in the multiple myeloma segment.
Secured approximately $100 million in financing, extending cash runway into Q2 2026 and supporting three core priorities: advancing clinical programs, growing the XPOVIO franchise, and maintaining financial discipline.

View recap

Krystal Biotech, Inc.

KRYS Q3 2025

Reported: 2025-11-05

Krystal Biotech delivered a strong Q3 2025, with VYJUVEK revenues reaching $97.8 million, bolstered by recent expansions in Europe and Japan. The company is well-positioned for sustained growth with an expanding prescriber base and new clinical programs underway.

Key takeaways

VYJUVEK revenues total $97.8 million for Q3, contributing to over $623 million since the product’s launch.
Gross margins remained robust at 96%, with an acceleration in over 40 new reimbursement approvals in the U.S. since the last earnings call.
Successful launches of VYJUVEK in Germany, France, and Japan are set to enhance patient access and treatment availability.
The updated U.S. label for VYJUVEK now includes patients from birth, optimizing the product's market position and potential for higher compliance.
Initiation of a new clinical program for Hailey-Hailey disease reinforces Krystal’s commitment to rare disease treatments and expands their innovative pipeline.

View recap

Kratos Defense & Security Solutions, Inc.

KTOS Q3 2025

Reported: 2025-11-05

Kratos Defense & Security Solutions reported robust third-quarter results, driving an increase in full-year revenue growth forecasts amidst rising defense demands. The company’s strategic investments position it for significant long-term opportunities.

Key takeaways

Full-year 2025 revenue growth forecast revised to 14%–15% organic growth, up from 11%–13%.
Anticipated EBITDA margin expansion of ~100 basis points in 2026 and another ~100 basis points in 2027 as the company scales operations.
Partnership with Northrop Grumman on the Valkyrie aircraft now a program of record with anticipated initial contract awards forthcoming.
New collaboration with Airbus to develop a German variant of the Valkyrie, reflecting substantial European defense spending opportunities.
Record level of new program opportunities identified, driven by ongoing government reforms in defense procurement practices.

View recap

Kura Oncology, Inc.

KURA Q3 2025

Reported: 2025-11-05

Kura Oncology's Q3 2025 performance highlights significant advancements in its clinical pipeline, particularly the promising trajectory of ziftomenib for acute myeloid leukemia, as it prepares for anticipated commercial launch.

Key takeaways

Ziftomenib's FDA review remains on track for a November 30, 2025, action date, with strong clinical data supporting its potential approval and market impact.
Positive results from the KOMET-001 study indicate ziftomenib's high response rates in combination with standard chemotherapy for newly diagnosed AML patients.
Kura's commercial readiness is robust, with preapproval marketing strategies exceeding targets and a fully aligned distribution network established for swift market entry.
The initiation of multiple Phase III trials (KOMET-017) targets broader patient populations in early disease stages, enhancing ziftomenib's positioning in the market.

View recap

Leidos Holdings, Inc.

LDOS Q3 2025

Reported: 2025-11-05

Leidos delivered robust Q3 2025 results with a 7% revenue growth, bolstered by significant operational cash flow of $711 million, prompting a second guidance raise for the year.

Key takeaways

Adjusted EBITDA margin improved to 13.8%, reflecting effective cost management and operational efficiency.
$0.5 billion counterterrorism contract rewon, demonstrating successful integration of automation and AI in operations.
Energy infrastructure segment remains strong with over $600 million in annual revenues and double-digit growth, capitalizing on a significant investment in U.S. energy infrastructure.
Leidos' NorthStar 2030 strategy is driving momentum across key growth pillars, focusing on customer-aligned outcomes and innovative solutions.
Continued resilience in operations during the government shutdown, with most projects classified as mission essential and unaffected.

View recap

Longeveron Inc.

LGVN Q3 2025

Reported: 2025-11-05

Longeveron reported significant advancements in Q3 2025, including the completion of enrollment in its pivotal HLHS clinical trial and a focused strategy to secure additional financing.

Key takeaways

Completed enrollment for the ELPIS II pivotal Phase IIb clinical trial, with results expected in Q3 2026, paving the way for potential regulatory approval.
Extended cash runway into late Q1 2026 through operational decisions and an at-the-market financing facility, with potential to raise up to $10.7 million if needed.
Focus on bolstering BLA preparedness ahead of the ELPIS II data release, with adjusted timelines for full BLA filing anticipated in 2027.

View recap

Liquidia Corporation

LQDA Q3 2025

Reported: 2025-11-05

Liquidia Corporation achieved a significant operational breakthrough in Q3 2025, with YUTREPIA generating $51.7 million in net sales during its first full quarter post-launch, positioning the company ahead of profitability expectations.

Key takeaways

YUTREPIA received over 2,000 unique prescriptions and initiated therapy for more than 1,500 patients within its first full quarter.
Positive adjusted EBITDA of $10.1 million marked a faster path to profitability than anticipated, with net cash flow becoming positive for the first month in September.
Approximately 75% of YUTREPIA patients are new to treprostinil, indicating strong market penetration and physician acceptance.
Liquidia plans to expand YUTREPIA's clinical utility via open-label studies and research into other potential indications like IPF and PPF.
Company's cash position strengthened with $157.5 million on hand, allowing for continued investment in innovation.

View recap

Intuitive Machines, Inc.

LUNR Q3 2025

Reported: 2025-11-05

Intuitive Machines reported Q3 revenue of $52.4 million while announcing its strategic acquisition of Lanteris Space Systems for $800 million, positioning itself as a competitive next-generation space prime provider.

Key takeaways

Revenue boosted primarily by ongoing projects including OMES, CLPS, and NSNS, with improved gross margin of $5.7 million.
Acquisition of Lanteris enhances production scale and reliability, aiming to capture growth across national security, civil, and commercial space sectors.
Company backlog stands at $235.9 million, reflecting ongoing contract momentum despite uncertainties in government funding.
Adjusted EBITDA loss narrowed to $13.2 million, an improvement of $12.2 million from the previous quarter, highlighting operational efficiency gains.

View recap

The Macerich Company

MAC Q3 2025

Reported: 2025-11-05

Macerich outperformed expectations in Q3 2025, achieving substantial leasing momentum and operational improvements, reinforcing confidence in its Path Forward strategy.

Key takeaways

Signed leases of 1.5 million square feet in Q3, an 87% increase year-over-year, driving total year-to-date leases to 5.4 million square feet.
Portfolio occupancy rose to 93.4%, up 140 basis points from the previous quarter, with a go-forward occupancy of 94.3%.
Positive leasing spreads of 5.9% for 16 consecutive quarters highlight the strength of recent leasing initiatives, including commitments on 74% of previously vacant Forever 21 space.
The acquisition of Crabtree Mall is expected to enhance leasing momentum, with ongoing projects projected to achieve incremental SNO growth of $140 million.
Strong commitment to new retail concepts, with 30 anchor openings targeted between 2025 and 2028, positioning Macerich for long-term occupancy and revenue growth.

View recap

Marathon Digital Holdings, Inc.

MARA Q3 2025

Reported: 2025-11-05

MARA continues its transformation from a Bitcoin miner to a vertically integrated digital infrastructure company, achieving significant advancements in both mining efficiency and AI inference capabilities this quarter.

Key takeaways

Installed first AI inference racks at the Granbury site, marking a strategic expansion into AI infrastructure.
Pending acquisition of Exaion will enhance MARA's capabilities in enterprise-grade AI-optimized private cloud services.
Collaboration with MPLX aims to develop integrated power generation and data center campuses, with the potential to expand capacity from 400 megawatts to 1.5 gigawatts.
Strategic shift emphasizes the dual monetization of energy through Bitcoin mining and AI, positioning MARA at the forefront of the digital economy.
Leadership believes the convergence of Bitcoin and AI will maximize energy value and drive future growth.

View recap

Matson, Inc.

MATX Q3 2025

Reported: 2025-11-05

Matson reported a challenging third quarter with declines in operating income attributed to reduced freight rates and container volumes in its China service, though domestic trade lanes showed resilience.

Key takeaways

Ocean Transportation operating income fell significantly, driven by a 12.8% drop in container volume in the China service and lower freight rates.
The company anticipates consolidated operating income for Q4 2025 to be approximately 30% lower year-over-year, despite optimism for a more stable trading environment following a U.S.-China trade agreement.
Domestic volumes increased in Hawaii (up 0.3%) and Alaska (up 4.1%), while Guam's volume decreased by 4.2%, reflecting varying local economic conditions.
Management remains committed to maintaining pricing strategies that do not pass on port entry fees to customers, emphasizing their service reliability.

View recap

McDonald's Corporation

MCD Q3 2025

Reported: 2025-11-05

McDonald's reported strong third-quarter performance with global comparable sales growth of 3.6%, driven by effective value offerings and menu innovations despite ongoing consumer challenges.

Key takeaways

Global system-wide sales rose over 6% in constant currency, benefiting from new unit openings and strategic execution.
The reintroduction of Extra Value Meals has improved value perceptions and is expected to enhance traffic among lower-income consumers.
Strong local marketing and menu innovation strategies contributed to market share gains in key international markets, particularly Australia and Japan.
U.S. comparable sales grew by 2.4%, reflecting successful product launches such as Snack Wraps and ongoing operational improvements.
Continued focus on high-growth categories like chicken and beverages is set to drive long-term growth amid evolving consumer preferences.

View recap

Mirum Pharmaceuticals, Inc.

MIRM Q3 2025

Reported: 2025-11-05

Mirum Pharmaceuticals reported strong third-quarter results, achieving $133 million in revenue — nearly a 50% year-over-year increase, driven by robust sales of LIVMARLI and a solid pipeline of clinical studies.

Key takeaways

LIVMARLI net product sales reached $92 million, supported by healthy demand across U.S. markets and strong international growth.
Company achieved positive net income for the first time, highlighting effective operational leverage in its business model.
Enrollment in the pivotal Phase IIb VISTAS study for volixibat in primary sclerosing cholangitis is complete, with top-line data expected in Q2 2026.
Full-year revenue guidance has been raised to $500 million-$510 million, reflecting sustained strong performance across product lines.
Continued growth potential anticipated for key products, with peak revenue opportunities exceeding $1 billion for LIVMARLI, volixibat, and MRM-3379.

View recap

Mowi ASA

MOWI.OL Q3 2025

Reported: 2025-11-05

Mowi reported a solid third quarter with operating revenues of EUR 1.39 billion, driven by record harvest volumes of 166,000 tonnes despite experiencing continued pricing pressure below industry costs.

Key takeaways

Achieved operational profit of EUR 112 million, with costs down EUR 50 million year-over-year thanks to stable production costs.
Successfully closed the acquisition of Nova Sea, set to deliver EUR 34 million in synergies and boost future harvest capacity.
Consumer and Feed divisions posted record earnings, highlighting strong performance in non-farming segments.
Board approved a quarterly dividend of NOK 1.50 per share, reflecting ongoing commitment to shareholder returns.
Farm volume guidance increased from 545,000 tonnes to 554,000 tonnes year-over-year, reinforcing Mowi's market leadership in Atlantic salmon.

View recap

Match Group, Inc.

MTCH Q3 2025

Reported: 2025-11-05

Match Group demonstrated strong financial performance in Q3 2025, exceeding revenue and adjusted EBITDA forecasts amid a strategic turnaround focused on user experience and engagement across its flagship brands, Tinder and Hinge.

Key takeaways

Revenue and adjusted EBITDA surpassed expectations, highlighting effective operational improvements and strategic focus.
Tinder's innovative features, like Chemistry and Modes, are driving engagement, particularly among Gen Z users, with a 30% increase in Double Date adoption.
Hinge's revitalized product positioning is attracting younger demographics, indicating potential for scalable growth.
The company is expanding its user base target to include approximately 250 million singles not currently on dating apps, with plans for user reactivation and acquisition.
Enhanced app performance, with significant reductions in crash rates and faster startup times, is set to improve overall user satisfaction.

View recap

Nuveen Churchill Direct Lending Corp.

NCDL Q3 2025

Reported: 2025-11-05

Nuveen Churchill Direct Lending Corp reported net investment income of $0.43 per share for Q3 2025, reflecting a strategic reduction in originations as the company maintained higher leverage levels amid stabilizing market conditions.

Key takeaways

Gross originations decreased to $29 million in Q3 from $48 million in Q2, aligning with management's strategy to optimize leverage.
Net asset value slightly declined to $17.85 per share due to fair value adjustments on underperforming portfolio companies.
Continued strength in M&A activity, bolstered by recent rate cuts, supports a positive outlook for private credit investments.
The pipeline for new deals increased by 22% from the previous quarter, with a focus on resilient sectors and senior lending.
NCDL remains insulated from recent market volatility affecting BDCs and continues to target high-quality, middle-market investments.

View recap

Natural Resource Partners L.P.

NRP Q3 2025

Reported: 2025-11-05

Natural Resource Partners L.P. reported a strong third quarter in 2025, generating $42 million in free cash flow despite ongoing challenges in coal and soda ash markets.

Key takeaways

Generated $42 million of free cash flow in Q3 2025 and $190 million over the last 12 months.
Expected near-term distribution from Sisecam Wyoming to remain suspended amid a generational bear market for soda ash.
Continues to retire debt aggressively, reducing outstanding debt to $70 million, with a goal to increase unitholder distributions by August 2026.
Coal markets face significant headwinds, with lessees operating close to production costs and no immediate catalysts for recovery.
The carbon-neutral industry struggles to gain traction, with all CO2 sequestration leases currently inactive.

View recap

The New York Times Company

NYT Q3 2025

Reported: 2025-11-05

The New York Times Company delivered robust third-quarter results, highlighted by a strong surge in digital subscriber growth and significant increases in both revenue and operating profit, affirming the effectiveness of its multifaceted business strategy.

Key takeaways

Added 460,000 net new digital subscribers, reaching a total of 12.3 million, positioning towards the 15 million milestone.
Digital subscription revenue rose 14%, driven by heightened audience engagement and enhanced product offerings including video and AI.
Advertising revenue surged, with digital advertising up over 20% and total advertising growing nearly 12%, reflecting a successful strategy to broaden the digital ad business.
Consolidated revenues grew approximately 9.5%, and adjusted operating profit increased by 26%, with AOP margin expanding by 240 basis points.
Generated $393 million in free cash flow year-to-date, returning $191 million to shareholders, aligning with the commitment to return at least 50% of free cash flow to investors.

View recap

Ocular Therapeutix, Inc.

OCUL Q3 2025

Reported: 2025-11-05

Ocular Therapeutix reported strong progress in its third quarter of 2025 with key milestones reached in its clinical trials for AXPAXLI, positioning the company for a potential market shift in retinal therapies.

Key takeaways

Successfully reached target randomization of 555 subjects in the SOL-R trial for wet AMD, indicating strong investigator engagement and execution.
Launched the HELIOS program aimed at gaining a superiority label for AXPAXLI in both diabetic retinopathy and non-proliferative diabetic retinopathy (NPDR), aiming to capture a broader patient population.
Phase III trial SOL-1 anticipates releasing top-line data in Q1 2026, which could position AXPAXLI as a distinct first-line treatment in a commoditized market currently dominated by anti-VEGF therapies.

View recap

Orion Engineered Carbons S.A.

OEC Q3 2025

Reported: 2025-11-05

Orion S.A. reported a challenging third quarter in 2025, with adjusted EBITDA of $58 million, significantly impacted by weak demand in its Rubber and Specialty segments, primarily due to lower tire production and heightened competition from imports.

Key takeaways

Adjusted EBITDA slightly exceeded preannounced figures but remained well below expectations due to reduced demand in key Western markets.
A new CFO has been appointed to strengthen financial leadership, set to start on December 1, 2025.
Soft demand in the Rubber segment is exacerbated by elevated tire imports and surplus inventories, with U.S. tire production down approximately 29%.
Orion is strategically focusing on improving structural costs and cash flow to adapt to the prevailing market headwinds.
Developments in the Specialty segment involve successful qualifications for new conductive carbon products, addressing strong demand in energy storage and data center applications.

View recap

ON Semiconductor Corporation

ON Q3 2025

Reported: 2025-11-05

onsemi delivered a strong Q3 2025, exceeding revenue expectations with $1.55 billion, a non-GAAP gross margin of 38%, and EPS of $0.63 while positioning for future growth in AI and power efficiency.

Key takeaways

Revenue grew by 7% sequentially in Automotive and 5% in Industrial, indicating positive market stabilization.
AI-related revenue doubled year-over-year, driven by a significant increase in customer demand, with expectations to reach nearly $250 million by 2025.
The launch of the vGaN platform enhances onsemi’s capabilities in high-efficiency power delivery, targeting sectors such as AI data centers and electric vehicles.
Strategic acquisitions, including Vcore, bolster the company's advanced analog and mixed-signal portfolio and support next-generation AI deployments.

View recap

Ormat Technologies, Inc.

ORA Q3 2025

Reported: 2025-11-05

Ormat Technologies reported a solid third quarter in 2025, with revenues up 17.9%, driven by robust performance in both the Energy Storage and Product segments, and announced an increase in revenue and adjusted EBITDA guidance for the year.

Key takeaways

Total revenue reached $249.7 million, a 17.9% year-over-year increase.
Operating income rose by 13.3%, while net income attributable to stockholders increased by 9.3%.
Significant milestones included a 25-year PPA extension for the Heber 1 facility and two exploration licenses in Indonesia, enhancing regional presence.
Energy Storage segment revenues surged 108% to $20.4 million, driven by successful facility commissions.
Adjusted EBITDA grew to $138.4 million, reflecting ongoing improvements despite some headwinds in tax benefit sales.

View recap

Ouster, Inc.

OUST Q3 2025

Reported: 2025-11-05

Ouster achieved its 11th consecutive quarter of revenue growth, reporting $39.5 million in Q3 2025, bolstered by strong demand for its advanced sensor solutions across various industries.

Key takeaways

Over 7,200 sensors shipped this quarter, driving record revenue and showcasing strong customer engagement.
Gross margin held firm at 42%, with cash reserves at $247 million and zero debt, highlighting a solid financial position.
Strategic partnerships and product innovations, including Ouster Gemini and REV7 sensors, are expanding market reach in logistics and autonomous sectors.
Continued progress towards profitability, with increased focus on scaling software solutions and enhancing AI capabilities across product lines.

View recap

Oxford Square Capital Corp.

OXSQ Q3 2025

Reported: 2025-11-05

Oxford Square Capital Corp reported a slight increase in net investment income for Q3 2025, alongside a decline in net asset value per share, impacted by significant losses on investments.

Key takeaways

Net investment income rose to $5.6 million ($0.07 per share) vs. $5.5 million ($0.08 per share) in the previous quarter.
Total investment income increased to approximately $10.2 million, up from $9.5 million in Q2 2025.
Combined net unrealized and realized losses reached $7.5 million, a significant increase compared to $1.1 million in the prior quarter.
The company issued approximately 5.4 million new shares for $11.8 million in net proceeds and $74.8 million in unsecured notes.
Monthly distributions of $0.035 per share were declared for the first three months of 2026, indicating ongoing shareholder returns.

View recap

Patria Investments Limited

PAX Q3 2025

Reported: 2025-11-05

Patria achieved a significant milestone with assets under management surpassing $50 billion, driven by robust organic fundraising of $1.5 billion in Q3 2025, positioning the firm to exceed its annual fundraising target.

Key takeaways

Fee-related earnings rose to $49.5 million, up 22% year-over-year, reflecting strong growth in fee-earning assets under management.
Distributable earnings increased 31% year-over-year to $46.9 million, driven by higher fee-related earnings.
Redemptions decreased by approximately 30% year-to-date, showcasing enhanced investment performance across offerings.
Patria recorded net organic inflows of $1.4 billion into fee-earning assets under management year-to-date, highlighting a 6% annualized organic growth rate.
Subsequent to the quarter, multiple monetization events are expected to generate $15 million in performance-related earnings for Q4, enhancing the firm's earnings outlook.

View recap

PotlatchDeltic Corporation

PCH Q3 2025

Reported: 2025-11-05

PotlatchDeltic reported a strong Q3 2025 with total adjusted EBITDA of $89 million, driven by robust performance in its real estate segment despite ongoing challenges in the lumber market.

Key takeaways

The real estate segment excelled with significant transactions, including $39 million from two rural sales in Georgia, and healthy demand for residential lots.
Adjusted EBITDA in the Wood Products business fell to a loss of $2 million due to soft lumber prices, despite achieving record low manufacturing costs.
Management announced a proposed merger of equals with Rayonier, projected to create $40 million in annual synergies and enhance operational efficiencies.
Strong performance in the Timberlands division with a planned harvest of 1.9 million tons, while market dynamics led to price stabilization for lumber products.
Continued expansion in natural climate solutions, with significant interest in solar and lithium development initiatives, reflecting strategic growth opportunities.

View recap

Public Service Enterprise Group Incorporated

PEG Q3 2025

Reported: 2025-11-05

PSEG reported strong third-quarter results, driven by the benefits of new distribution rates and robust capital investments, allowing for an upward revision of its 2025 non-GAAP operating earnings guidance.

Key takeaways

Non-GAAP operating earnings guidance for 2025 narrowed to $4.00-$4.06 per share, up from $3.94-$4.06.
Capital spending of $1 billion during Q3, contributing to a total of $2.7 billion year-to-date as part of a $3.8 billion annual program focused on modernizing infrastructure.
PSEG Nuclear delivered 7.9 terawatt hours of carbon-free energy, with an extension of the Hope Creek unit's fuel cycle to 24 months enhancing operational efficiency.
The Board of Trustees of the Long Island Power Authority approved a 5-year contract extension for PSEG as service provider through 2030.
The company maintains a 5-year operating earnings growth outlook of 5% to 7% through 2029, supported by a robust balance sheet and capital investment program.

View recap

Pfizer Inc.

PFE Q3 2025

Reported: 2025-11-05

Pfizer reported strong third-quarter 2025 results, leveraging strategic partnerships and clinical advancements to enhance its competitive position in the pharmaceutical landscape.

Key takeaways

Established a landmark agreement with the U.S. government, addressing key policy impacts and committing to U.S. manufacturing investments.
Advanced the proposed acquisition of Metsera, with potential to enhance Pfizer’s portfolio in obesity treatments despite external competitive offers.
Received encouraging Phase II clinical data for SSGJ-707, with plans for a robust clinical development program to unlock its potential.
Presented breakthrough results at ESMO from multiple oncology studies, reinforcing portfolio strength and expanding addressable patient populations across various cancer types.

View recap

Pinterest, Inc.

PINS Q3 2025

Reported: 2025-11-05

Pinterest achieved robust growth in Q3 2025, with a 17% year-over-year revenue increase to $1.049 billion and continued expansion in user engagement, particularly among Gen Z.

Key takeaways

Monthly active users reached 600 million, marking nine consecutive quarters of record growth, powered primarily by Gen Z, which makes up over 50% of the user base.
Revenue growth driven by a significant increase in visual search engagement, with queries up 44% year-over-year.
Outbound clicks to advertisers surged by 40% year-over-year, highlighting Pinterest’s strengthened performance ad platform.
Clear international monetization opportunities exist, as markets remain significantly undermonetized, indicating future growth potential.
Pinterest's AI-driven platform enhances user experience and ad performance, positioning it as a crucial partner for advertisers in a competitive landscape.

View recap

Palantir Technologies Inc.

PLTR Q3 2025

Reported: 2025-11-05

Palantir reported a standout Q3 2025 with revenue up 63% year-over-year, driven by robust growth in its U.S. commercial business, highlighting strong demand for its AI platform.

Key takeaways

Q3 total revenue reached $2.8 billion, with U.S. commercial revenue up 121% year-over-year, reflecting increasing enterprise AI adoption.
The company achieved a Rule of 40 score of 114%, underscoring excellent operational efficiency and growth.
Palantir closed its highest total contract value (TCV) quarter ever, signing 204 deals above $1 million, including significant expansions from key customers.
U.S. government business grew by 52% year-over-year, reinforcing Palantir's commitment to delivering mission-critical software.
Significant advancements in AI applications within AIP demonstrate the company's capability to meet increasing demand for enterprise AI solutions.

View recap

Pinnacle West Capital Corporation

PNW Q3 2025

Reported: 2025-11-05

Pinnacle West Capital Corporation reported Q3 2025 earnings of $3.39 per share, reflecting steady growth in transmission revenues and overall sales, while revising guidance upward to account for strong demand and operational improvements.

Key takeaways

Increased transmission revenue and robust sales growth led to a $0.02 year-over-year EPS increase.
Revised 2025 EPS guidance raised to $4.90-$5.10, indicating strong operational outlook amidst rising customer demand.
Achieved 5.4% weather-normalized sales growth, driven by significant contributions from commercial and industrial segments.
Palo Verde Generating Station operated at full capacity throughout the summer, ensuring reliability amid peak demand.
Ongoing investments in both generation and transmission infrastructure are positioned to support future growth and enhance grid reliability.

View recap

PROCEPT BioRobotics Corporation Common Stock

PRCT Q3 2025

Reported: 2025-11-05

PROCEPT BioRobotics reported robust third quarter 2025 results, achieving $83.3 million in total revenue, a 43% year-over-year increase, driven by strong capital system sales. The company remains focused on enhancing procedure utilization and expanding market awareness for its innovative Aquablation therapy.

Key takeaways

Total revenue reached $83.3 million, with U.S. sales contributing $73.9 million, showcasing solid growth amidst market scrutiny.
58 U.S. capital systems shipped in the quarter, indicating a stable pricing environment despite tightening capital budgets in large hospital systems.
Organizational changes aimed at improving commercial execution, including expedited new account launches and a sharpened focus on international markets.
Potential expansion into prostate cancer treatment, supported by the ongoing WATER IV clinical trial, highlights the long-term growth opportunities beyond BPH.
Commitment to enhancing patient awareness and accelerating therapy adoption, leveraging new talent within leadership.

View recap

Purple Innovation, Inc.

PRPL Q3 2025

Reported: 2025-11-05

Purple Innovation's Q3 2025 earnings show a revenue increase to $118.8 million, marking a turnaround after consecutive declines, alongside significant improvements in gross margin and adjusted EBITDA.

Key takeaways

Achieved positive adjusted EBITDA, reflecting streamlined operations and cost-saving measures expected to yield annual savings of $25–30 million.
Gross margin improved nearly 700 basis points sequentially to 43%, despite ongoing tariff pressures.
Continued strong performance of the Rejuvenate 2.0 mattress collection, doubling revenue compared to its predecessor and boosting showroom sales by 6.5%.
E-commerce revenue is down 10% but shows signs of recovery following recent site enhancements and improving traction on Amazon.
Wholesale revenue grew 8% due to the expanding Mattress Firm partnership, aiding overall business stabilization.

View recap

Personalis, Inc.

PSNL Q3 2025

Reported: 2025-11-05

Personalis achieved significant growth in Q3 2025 with a 364% year-over-year increase in clinical tests, reflecting strong demand for its ultrasensitive NeXT Personal test, while adjusting revenue guidance due to biopharma project timing variability.

Key takeaways

Revenue of $14.5 million surpassed expectations, driven by 4,388 clinical tests delivered in the quarter.
Growth in clinical adoption highlighted by over 700 physicians now ordering NeXT Personal.
Submitted additional coverage application for lung cancer, with three dossiers currently under review by MolDX.
Despite uneven biopharma spending, underlying demand for MRD technology remains strong, supporting long-term growth strategy.
Full-year revenue guidance adjusted to $68 million - $73 million, reflecting project timing volatility rather than demand changes.

View recap

Postal Realty Trust, Inc.

PSTL Q3 2025

Reported: 2025-11-05

Postal Realty Trust reported strong third-quarter results with a 10% year-over-year growth in AFFO per share, underscoring continued momentum in its strategic initiatives and an increase in 2025 guidance.

Key takeaways

AFFO per share reached $0.33, marking a 10% increase compared to the previous year, with 2025 AFFO guidance raised by $0.06.
The company completed $42.3 million in acquisitions during the quarter at a weighted average cash cap rate of 7.7%, with full-year acquisitions expected to exceed $110 million.
Updated same-store cash NOI guidance has been raised to between 8.5% and 9.5%, up from the prior 7% to 9% range.
Introduction of an efficient leasing framework has improved revenue predictability, allowing for the first annual AFFO guidance disclosure since inception.
Appointment of Steve Bakke as Chief Financial Officer is expected to strengthen capital markets positioning and investor relations.

View recap

Portillo's Inc. Class A Common Stock

PTLO Q3 2025

Reported: 2025-11-05

Portillo's reported a modest revenue increase of 1.8% year-over-year in Q3 2025, but faced challenges with a 0.8% decline in same-restaurant sales, attributed to decreased transactions.

Key takeaways

Revenues reached $181.4 million, with $5.6 million contributed by new restaurants outside the comparable base.
Same-restaurant sales fell 0.8% due to a 2.2% decrease in transactions, despite a 1.4% rise in average check.
Strategic reset announced to slow development, focusing on improving guest experience and unit economics in new markets.
Smaller restaurant formats are being explored to enhance profitability in initial volumes.
Portillo's Perks loyalty program shows early promise in driving customer visits and engagement.

View recap

Parex Resources Inc.

PXT.TO Q3 2025

Reported: 2025-11-05

Parex Resources achieved notable operational performance in Q3 2025, with production increasing significantly post-acquisition while maintaining strong financial results despite a challenging price environment.

Key takeaways

Production averaged 43,953 BOE per day for Q3, with October leveraging a 12% month-over-month increase to 49,300 BOE per day.
Successful operational initiatives boosted production at key assets, particularly Llanos 32, where output more than tripled since acquisition.
Funds flow from operations grew slightly to $105 million, with a steady FFO netback of $26.07 per BOE against an average Brent price of $68.17.
Capital spending totaled $80 million, reflecting the ramp-up in activity, while strategic hedges help mitigate cash flow volatility in the upcoming quarter.
The company maintains a strong balance sheet and liquidity, underpinning ongoing investments and a regular dividend, with potential for increased capital deployment in 2026 based on upcoming well results.

View recap

Qualys, Inc.

QLYS Q3 2025

Reported: 2025-11-05

Qualys delivered strong Q3 2025 results, driven by robust revenue growth and increased customer adoption of its proactive risk management solutions, positioning the company as a leader in cybersecurity.

Key takeaways

Q3 revenue growth driven by rising demand for Agentic AI-powered risk management solutions, enhancing the alignment of cybersecurity with business objectives.
Attendance at the recent Risk Operations Conference increased by 20%, underscoring growing interest in centralized risk management.
Successful launch of TruConfirm, which validates exploitability before breaches occur, emphasizing Qualys's commitment to proactive remediation strategies.
Recognition as a leader in Patch Management with over 140 million patches deployed, showcasing Qualys's operational efficiency and innovation in cybersecurity solutions.
Customer growth in substantial spending categories, with the number of clients spending over $500,000 increasing by 5% year-over-year.

View recap

Ferrari N.V.

RACE Q3 2025

Reported: 2025-11-05

Ferrari's Q3 2025 results reflect strong strategic initiatives and a refined outlook on powertrain offerings, positioning the company for sustainable long-term growth despite macroeconomic challenges.

Key takeaways

Achieved approximately 30% reduction in Scope 1 and Scope 2 emissions since 2021, with ambitious targets set for further decarbonization by 2030.
Revised powertrain strategy now targets 40% Internal Combustion Engine (ICE), 40% hybrid, and 20% electric models by 2030, adapting to current market dynamics and client preferences.
Launched the Ferrari Amalfi and the Testarossa family, while planning for the highly anticipated electric model, the Ferrari Elettrica, with its complete reveal scheduled for Q2 2026.
Set an aspirational financial target of €9 billion in revenues by 2030, demonstrating confidence in Ferrari's brand strength and long-term growth strategy.
Expanded active client base to 90,000, enhancing customer engagement through exclusive lifestyle experiences and maintaining brand exclusivity.

View recap

Rapid7, Inc.

RPD Q3 2025

Reported: 2025-11-05

Rapid7 reported Q3 2025 revenue of $218 million, exceeding expectations, while its annual recurring revenue (ARR) grew modestly to $838 million amid internal leadership changes aimed at accelerating go-to-market strategies.

Key takeaways

ARR increased 2% year-over-year to $838 million, though the company acknowledged a need to scale back its previous guidance.
Q3 operating income reached $37 million, highlighting effective cost management alongside revenue growth.
Free cash flow remained robust at $30 million, reflecting strong operational efficiency.
Recent leadership changes, including a new Chief Commercial Officer and planned operational adjustments, are intended to reinvigorate growth, particularly in the managed detection and response (MDR) sector.
The company is focusing on its AI-powered security operations platform to deliver comprehensive solutions and improve deal cycles despite industry-wide challenges.

View recap

Revolve Group, Inc.

RVLV Q3 2025

Reported: 2025-11-05

Revolve Group delivered a solid Q3 2025, with a 45% year-over-year increase in adjusted EBITDA to a record $25 million, driven by impressive gross margin expansion despite only 4% net sales growth.

Key takeaways

Achieved gross margin of 54.6%, a nearly 350 basis point increase year-over-year, significantly surpassing expectations.
Adjusted EBITDA rose 45% year-over-year, highlighting strong operational performance amid challenging market conditions.
Free cash flow more than tripled in the first nine months of 2025, bolstering cash position by 25% to $63 million.
Ongoing investments in international markets and brand activations are expected to bolster long-term growth prospects, particularly in Mainland China.

View recap

Sanmina Corporation

SANM Q4 2025

Reported: 2025-11-05

Sanmina reported a robust fourth quarter for fiscal 2025, with revenue of $2.1 billion and a non-GAAP EPS of $1.67, reflecting a year-over-year revenue growth of 3.9% and significant operating margin expansion.

Key takeaways

Total fiscal 2025 revenue reached $8.13 billion, up 7.4% year-over-year, driven by strong demand in communication networks and AI sectors.
Non-GAAP operating margin improved by 30 basis points year-over-year to 5.7%, with a fourth quarter margin of 6.0%.
Generated a strong cash flow from operations of $621 million, underscoring financial health and operational efficiency.
Non-GAAP EPS for fiscal 2025 was $6.04, representing a 14.4% increase from the prior year.
Continued strategic investments contributed to an increase in operating expenses, positioned for future growth.

View recap

Solaris Energy Infrastructure Inc.

SEI Q3 2025

Reported: 2025-11-05

Solaris Energy Infrastructure achieved record revenue and profit in Q3 2025, driven by robust demand for power solutions in the data center sector and strategic capacity expansions.

Key takeaways

Quarterly operational capacity surged to approximately 760 megawatts, an increase from 150 megawatts year-over-year.
Pro forma generation capacity is projected to rise to 2,200 megawatts by early 2028, surpassing previous estimates due to new orders.
Successful capital raise through convertible notes enhances financial flexibility, allowing for continued investment in growth.
Acquisition of HVMVLV strengthens service offerings and broadens customer base in high-growth markets.
Expanded executive leadership with Amanda Brock as co-CEO aims to enhance operational efficiency and strategic direction.

View recap

Siemens Healthineers AG

SHL.DE Q4 2025

Reported: 2025-11-05

Siemens Healthineers finished fiscal year 2025 with solid growth, exceeding guidance driven by strong global demand, while maintaining a robust book-to-bill ratio.

Key takeaways

Q4 revenue growth reached 6.5%, contributing to a full-year growth of 6.8%, led by Imaging and Varian segments.
Adjusted EPS exclusion of tariffs showed a 10% year-over-year increase, reflecting strong operational performance.
Proposed dividend increased to EUR 1 alongside improvements in free cash flow, reducing leverage to 2.8x EBITDA.
Book-to-bill ratio for equipment was at 1.12, indicating a healthy sales pipeline despite stagnant performance in China.
Diagnostics segment margin improvement continues, although revenue growth is subdued due to market challenges in China.

View recap

Sprott Inc.

SII.TO Q3 2025

Reported: 2025-11-05

Sprott Inc. reported strong Q3 results with assets under management (AUM) surpassing $49 billion, fueled by rising precious metals prices and notable inflows, alongside a dividend increase of 33%.

Key takeaways

Q3 AUM grew by $9 billion, marking a 56% increase year-over-year and surpassing $51 billion post-quarter.
Adjusted EBITDA rose 54% year-over-year to $31.9 million, driven by higher average AUM and market value appreciation.
Sprott declared a quarterly dividend of $0.40 per share, reflecting strong operational performance and a commitment to returning capital to shareholders.
The company's ETF business has seen substantial growth, with total assets reaching over $4.4 billion from a previous $400 million.
A strong management reshuffle positions Sprott for future growth, naming Ryan McIntyre as President and co-COOs Kevin Hibbert and Arthur Einav.

View recap

Soleno Therapeutics, Inc.

SLNO Q3 2025

Reported: 2025-11-05

Soleno Therapeutics delivered exceptional third quarter results, with net revenues more than doubling to $66 million, culminating in a positive net income of $26 million as VYKAT XR establishes itself in the market as a crucial treatment for Prader-Willi syndrome (PWS).

Key takeaways

Achieved over 764 active patients on VYKAT XR six months post-launch, signaling strong market adoption.
Total net revenue surged more than 100% from Q2, highlighting robust growth momentum.
Despite a temporary disruption from a short seller report, patient engagement initiatives led to a rebound in therapy initiation as awareness and education advance.
Ongoing preparations for a marketing authorization application in the EU could significantly expand the addressable market for VYKAT XR.
Discontinuation rates remain below expectations, reflecting manageable safety concerns and effective patient management strategies.

View recap

Spotify Technology S.A.

SPOT Q3 2025

Reported: 2025-11-05

Spotify delivered an impressive Q3 2025 performance, surpassing 700 million monthly active users, along with strong revenue and operating income growth, driven by enhanced user engagement and strategic initiatives.

Key takeaways

Monthly active users exceeded guidance, reaching 700 million, reflecting strong user fundamentals and engagement across all formats.
Continued growth in subscriber numbers and retention rates, despite recent price increases in over 150 markets, showcases loyalty and value of the platform.
Innovative product launches and direct licensing deals are enhancing Spotify’s competitive positioning and driving improved artist and podcaster relationships.
The successful rollout of an enhanced free experience significantly boosted user acquisition, integrating millions of new listeners into the Spotify ecosystem.
Leadership transition plans are in place, with a strategic focus on innovation and long-term company growth under the new co-CEO structure.

View recap

SSR Mining Inc.

SSRM Q3 2025

Reported: 2025-11-05

SSR Mining reported a solid third quarter with 103,000 gold equivalent ounces produced and $409 million in cash, positioning the company well for growth despite being on track for lower production guidance.

Key takeaways

Generated $72 million in free cash flow prior to working capital adjustments, despite increased AISC of $2,359 per ounce due to higher royalty costs.
Cash position remains robust with $409 million in cash and total liquidity exceeding $900 million, supporting ongoing investments in growth initiatives like Hod Maden.
On track to complete full year production guidance of 410,000 to 480,000 gold equivalent ounces, anticipating a stronger fourth quarter.
Progress on multiple projects, including upcoming technical reports for Cripple Creek & Victor and continued investment in organic developments across the portfolio.
Net income of $65.4 million reflects strong operational performance, with adjusted net income at $68.4 million for the quarter.

View recap

SuRo Capital Corp.

SSSS Q3 2025

Reported: 2025-11-05

SuRo Capital reported a strong third quarter for 2025, with a notable increase in net asset value driven by strategic investments in AI infrastructure companies like CoreWeave and OpenAI.

Key takeaways

Net asset value increased to $9.23 per share, up from $9.18 in the previous quarter and significantly higher than $6.73 a year ago.
CoreWeave is now one of the fastest-growing infrastructure providers, with stock trading approximately 3x its IPO price.
OpenAI is positioning for a potential $1 trillion IPO, translating to a valuation over 6x SuRo's initial entry point.
VAST Data is gaining traction and reportedly discussing a funding round at a valuation over 3x SuRo's entry.
SuRo's focus on AI infrastructure is yielding strong results, reinforcing investor confidence in its strategic positioning during a critical technology evolution.

View recap

Supernus Pharmaceuticals, Inc.

SUPN Q3 2025

Reported: 2025-11-05

Supernus Pharmaceuticals reported robust third-quarter results, driven by strong performances from key growth products including Onapgo, Qelbree, GOCOVRI, and collaboration revenues from Zurzuvae.

Key takeaways

Total revenue reached $192.1 million, a 9.5% increase year-over-year, driven by a significant uptick in net product sales.
Onapgo's net sales soared to $6.8 million, up from $1.6 million in Q2, highlighting strong initial demand amid supply constraints.
Collaboration revenue from Zurzuvae accounted for $20.2 million, showing a 150% increase year-over-year since the acquisition of Sage.
Qelbree and GOCOVRI reported net sales growth of 31% and 15%, respectively, reflecting strong market demand in both pediatric and adult segments.
The company expects to achieve annual synergies of up to $200 million from the Sage acquisition by mid-2026.

View recap

Molson Coors Beverage Company

TAP Q3 2025

Reported: 2025-11-05

Molson Coors delivered a challenging third quarter marked by industry-wide headwinds, yet showcased resilience through a robust balance sheet and strategic brand management under new CEO Rahul Goyal.

Key takeaways

Reported weaker consumption patterns driven by macroeconomic factors, particularly affecting lower-income and Hispanic consumer segments in the U.S.
Strong portfolio focus with plans to enhance marketing initiatives for core brands like Miller Lite and Coors Light, aiming for market share growth.
Plans to increase investment in premiumization across the beer and beyond beer segments, leveraging early success with brands like Peroni, which saw a 25% volume increase.
Continued commitment to strengthening the Blue Moon brand despite recent challenges, with a fresh commercial perspective to drive better performance.
The transition to Goyal as CEO indicates a strategic shift aimed at navigating current industry dynamics and capitalizing on long-term growth opportunities.

View recap

Teradata Corporation

TDC Q3 2025

Reported: 2025-11-05

Teradata reported strong Q3 2025 results, exceeding revenue and earnings per share expectations, while achieving positive annual recurring revenue (ARR) growth ahead of schedule, indicating a robust growth trajectory.

Key takeaways

Non-GAAP earnings per share of $0.72, significantly above guidance; free cash flow also exceeded expectations.
Positive ARR growth achieved two quarters ahead of the initial target, reinforcing confidence in sustainable growth for 2026.
Strong demand for Agentic AI solutions reflects a shift towards hybrid environments, allowing enterprises to maximize both on-prem and cloud data capabilities.
Recognized as a leader in Forrester Wave for Data Management for Analytics platforms, underlining Teradata's reliability and scalability in hybrid cloud deployments.
Recent launches, including Teradata AgentBuilder and integrated AI services, position the company at the forefront of accelerating enterprise-scale AI implementations.

View recap

Tempus AI, Inc. Class A Common Stock

TEM Q3 2025

Reported: 2025-11-05

Tempus AI reported a strong Q3 2025, achieving robust growth in both Genomics and Data Licensing, culminating in the company’s first positive adjusted EBITDA.

Key takeaways

Genomics volume surged 33% overall, with notable growth in Hereditary (37%) and Oncology (27%).
The Data Licensing segment grew 38%, adding $150 million in total contract value.
Achieved positive adjusted EBITDA for the first time, a significant milestone after 10 years, despite expenses from the Paige acquisition.
Growth is underpinned by improved sales efficiency and advancements in their integrated technology offerings.
Adjusted EBITDA for the full year is now expected to be slightly positive, even accounting for additional costs from acquisitions.

View recap

TG Therapeutics, Inc.

TGTX Q3 2025

Reported: 2025-11-05

TG Therapeutics reported robust Q3 2025 results, highlighted by impressive sales growth for BRIUMVI, which continues to outperform market expectations. The company remains committed to innovation and disciplined financial management.

Key takeaways

BRIUMVI generated approximately $153 million in U.S. net sales for Q3, exceeding internal targets and market forecasts.
Enrollment in pivotal studies for a simplified dosing schedule and subcutaneous ublituximab is progressing well, with potential launches anticipated in 2027 and 2028, respectively.
The recently completed $100 million share repurchase program and an additional authorized program reflect TG's commitment to returning capital to shareholders.
Continued strong demand and physician engagement for BRIUMVI highlight the growing preference for anti-CD20 therapies in MS treatment.
Intermediate data reveals significant efficacy and safety of BRIUMVI, with 90% of patients remaining free from disability progression after six years of treatment.

View recap

Toast, Inc.

TOST Q3 2025

Reported: 2025-11-05

Toast delivered a robust third quarter with 34% revenue growth and surpassed $2 billion in annual recurring revenue (ARR) for the first time, positioning the company for sustained expansion in the restaurant technology sector.

Key takeaways

Achieved 34% year-over-year revenue growth and 35% gross margins amid continued strong performance in net location adds.
Secured major partnerships with brands like Nordstrom and TGI Fridays, emphasizing Toast’s growing influence in various restaurant segments.
International SaaS ARPU increased by 20% year-over-year, reflecting successful market expansion and competitive platform offerings.
Expanded partnerships, including a collaboration with Uber, to enhance off-premise sales capabilities for restaurant clients.

View recap

TPG Inc. Class A Common Stock

TPG Q3 2025

Reported: 2025-11-05

TPG reported a strong third quarter with significant growth in assets under management (AUM) and fee-related earnings, underscored by a record $18 billion in capital raised.

Key takeaways

Achieved GAAP net income of $67 million and $214 million in after-tax distributable earnings, equating to $0.53 per share.
Total AUM grew 20% year-over-year, with fee-related earnings up 18%, reflecting robust capital formation and deployment.
Fundraising surged, with $18 billion raised, a 60% increase from Q2 and a 75% year-over-year jump, driven by private equity and credit sectors.
Successfully deployed a record $15 billion, marking a 70% increase year-over-year, with a significant contribution from credit strategies.
Enhanced penetration into insurance and private wealth channels, contributing to over $1 billion raised in these sectors during the quarter.

View recap

Trex Company, Inc.

TREX Q3 2025

Reported: 2025-11-05

Trex Company reported a challenging third quarter in 2025, with revenues 5% below guidance due to easing consumer demand; however, strong profitability and a robust new product pipeline signal promising future growth.

Key takeaways

New products contributed 25% of trailing 12-month sales, up from 18% in the prior year.
Adjusted EBITDA rose 33% despite a 15% increase in SG&A expenses, showcasing operational efficiencies.
Railing sales tracking double-digit year-on-year growth, supported by innovative product launches.
Progress on a new production facility in Arkansas is exceeding expectations, poised to enhance efficiency.
Anticipating muted fourth quarter sales but strategically positioned for recovery in early 2026.

View recap

Trimble Inc.

TRMB Q3 2025

Reported: 2025-11-05

Trimble's third-quarter 2025 results exceeded expectations with strong revenue growth and margins, prompting an upward revision of full-year guidance. The company's strategic focus on integrating AI into its offerings while enhancing its presence in key markets showcases its robust execution of the Connect & Scale strategy.

Key takeaways

Revenue reached $901 million, an 11% year-over-year increase, with a 63% contribution from recurring revenue.
Adjusted EPS increased by 16% to $0.81, demonstrating solid profitability and operational leverage.
Annual recurring revenue (ARR) grew 15% to $2.31 billion, driven by a robust 17% increase in the AECO segment.
Strong demand in core markets, particularly civil construction and AI data centers, showcased resilience amid economic headwinds.
Key partnerships with RFK Racing and Liverpool FC reinforce Trimble's commitment to leveraging its technology in high-profile industries.

View recap

Telesat Corporation Class A Common Shares and Class B Variable Voting Shares

TSAT Q3 2025

Reported: 2025-11-05

Telesat's Q3 2025 results reflect operational challenges, highlighted by a significant revenue decline due to contract renegotiations, though LEO segment development shows promising progress.

Key takeaways

Revenues decreased by $37 million to $101 million, primarily due to a lower rate from DISH on the Nimiq 5 contract and the expiration of the Anik F3 contract.
Adjusted EBITDA fell to $47 million with an adjusted EBITDA margin of 46%, impacted by increased operating expenses linked to Telesat Lightspeed initiatives.
Despite revenue challenges, Telesat reported strong interest in its LEO offerings, with a first satellite launch planned for late next year and efforts underway to enhance its capital structure.
Year-to-date cash generated from operations reached $97 million, with a solid cash position of $483 million.
Telesat continues to expect 2025 revenues in the range of $405 million to $425 million amid ongoing investments in its satellite technology.

View recap

UMH PROPERTIES, INC

UMH Q3 2025

Reported: 2025-11-05

UMH Properties reported a 4% increase in normalized FFO per diluted share to $0.25 for Q3 2025, driven by strong revenue growth and improved occupancy rates.

Key takeaways

Total revenue rose 10% year-over-year to $66.9 million, positioning the company on track to exceed $250 million in total income for 2025.
Same property NOI increased by 12% year-over-year, reflecting effective management and operational efficiency.
The portfolio occupancy rate improved to 87.2%, with plans to add 700 to 800 new rental homes by year-end, further enhancing revenue potential.
The company issued $80 million in new bonds to fund growth initiatives, indicating a shift towards debt financing for future expansions.

View recap

Urban One, Inc.

UONEK Q3 2025

Reported: 2025-11-05

Urban One reported a challenging third quarter with consolidated net revenue declining by 16% year-over-year and an adjusted EBITDA drop of 44%. The company has adjusted its full-year EBITDA guidance downwards due to persistent revenue headwinds.

Key takeaways

Consolidated net revenue of $92.7 million, down 16% YoY, with Radio Broadcasting segment revenue decreasing 12.6%.
Adjusted EBITDA fell to $14.2 million, a 44% decline compared to the prior year, attributed to reduced advertising revenues and ongoing political headwinds.
The company implemented a second reduction in force, resulting in $1.6 million in severance costs, as part of broader cost-saving measures amounting to $3 million annually.
Local ad sales demonstrated resilience, declining only 6.5% versus a broader market decline of 10.1%, while national sales lagged with a 29.1% fall.
Full-year EBITDA guidance revised to $56 million - $58 million, down from the prior guidance of $60 million due to softer Q3 performance.

View recap

Upstart Holdings, Inc.

UPST Q3 2025

Reported: 2025-11-05

Upstart's third quarter demonstrated robust financial growth with 71% revenue increase and significant improvements in operational metrics, despite a slight decline in loan conversion rates due to macroeconomic responses.

Key takeaways

Revenue increased by 71% year-on-year, with transaction volume growth of 80%.
GAAP net income surged sixfold compared to the prior quarter, reflecting strong profitability.
New product lines including auto and home loans accounted for nearly 12% of total originations, with auto transactions growing over 300% year-on-year.
Upstart expanded funding partnerships, adding seven new bank and credit union partners, positioning the company for continued growth.
Strong demand for AI-driven credit solutions was evidenced by over 2 million applications in Q3, the highest volume in three years.

View recap

Energy Fuels Inc

UUUU Q3 2025

Reported: 2025-11-05

Energy Fuels reported robust Q3 results, showcasing increased uranium production and a significant advancement in its rare earth segment, positioning the company for heightened gross margins in 2026.

Key takeaways

Achieved a 1.1 to 1.4 million-pound uranium production guidance for Q1 2026, bolstered by the ramp-up at the Pinyon Plain mine.
Successfully secured a $700 million upsized convertible note offering, enhancing financial flexibility.
Progress in rare earth production, with a qualification for NdPr resulting in contracts with major automotive manufacturers.
Working capital nearing $1 billion post-quarter, signaling strong liquidity and operational readiness.
Positive developments in partnerships, notably with the Navajo Nation, fostering community relations and operational support.

View recap

Veracyte, Inc.

VCYT Q3 2025

Reported: 2025-11-05

Veracyte delivered robust financial performance in Q3 2025, achieving 14% revenue growth year-over-year and a record adjusted EBITDA margin of 30%. The company's strategic focus on core testing products continues to drive impressive volume growth.

Key takeaways

Total revenue reached approximately $132 million, bolstered by 26% growth in Decipher and 13% growth in Afirma tests.
Adjusted EBITDA margin improved by 650 basis points year-over-year, surpassing the previously set goal of 25%.
Decipher's testing volume exceeded 26,700, marking the 14th consecutive quarter of over 25% year-over-year growth and demonstrating increased clinical utility for advanced disease management.
Strong research backing with 240 publications on Decipher, continuing to establish its relevance in prostate cancer treatment and diagnostics.

View recap

Vertex, Inc.

VERX Q3 2025

Reported: 2025-11-05

Vertex Inc. reported a strong third quarter, with revenue growth driven by cloud and subscription services, despite challenges from customer turnover and bankruptcies. Adjusted EBITDA reached a record high, demonstrating effective cost management and operational leverage.

Key takeaways

Revenue of $192.1 million, up 12.7% year-over-year, with cloud revenue growing 29.6%.
Adjusted EBITDA of $43.5 million, exceeding guidance by $2.5 million, resulting in a margin of 22.6%.
Annual recurring revenue increased 12.4% to $648.2 million; customer count grew 14%.
Significant share repurchase program announced, authorizing up to $150 million, indicating confidence in long-term growth.
Strong momentum in e-invoicing and ongoing improvements in cost management enhance future growth prospects.

View recap

Viper Energy Partners LP

VNOM Q3 2025

Reported: 2025-11-05

Viper Energy's Q3 2025 results demonstrate robust growth and enhanced return of capital, highlighted by the successful acquisition of Sitio and significant dividend increases amid ongoing operational strength.

Key takeaways

Achieved a 20% increase in oil production per share year-over-year in Q4 2025 guidance; projecting mid-single-digit organic oil growth into 2026.
Returned 85% of cash available for distribution to shareholders, translating to a 48% increase in return of capital per Class A share from Q2.
Completed over $90 million in share repurchases during the quarter, with plans to continue aggressive buybacks driven by favorable market conditions.
Positioned to return nearly 100% of free cash flow to shareholders following the recent $700 million asset sale, with a focus on dividends and buybacks.
Captured nearly 50% of all drilling activity in the Permian Basin, enhancing competitive advantage and positioning for long-term growth.

View recap

Westpac Banking Corporation

WBC.AX Q4 2025

Reported: 2025-11-05

Westpac's FY 2025 results reflect strategic growth initiatives amid rising costs, with a net profit of $7 billion and a maintained dividend, underscoring the bank's commitment to operational excellence and customer engagement.

Key takeaways

Net profit decreased 2% to $7 billion, with statutory net profit down 1% to $6.9 billion.
Cost-to-income ratio increased to 53%, necessitating further focus on the "Fit for Growth" program to manage expenses.
Full-year dividend declared at $1.53 per share, equating to a payout ratio of 75% of profits after tax.
Strong deposit growth with a 10% increase in consumer deposits and 11% in public sector deposits, indicating robust customer trust and engagement.
Continued investment in digital innovations like Biz Edge and Westpac One aims to enhance service quality and operational efficiency.

View recap

The Williams Companies, Inc.

WMB Q3 2025

Reported: 2025-11-05

The Williams Companies delivered strong financial performances in Q3 2025, with adjusted EBITDA rising 13% year-over-year to $1.92 billion, driven by successful expansion projects and strategic partnerships.

Key takeaways

Successful completion of key transmission and expansion projects led to record revenues, particularly from the Transco pipeline.
Strategic divestiture of upstream assets for $398 million, redirecting capital towards high-quality pipeline and LNG terminal projects with 20-year customer contracts.
Projected $1.9 billion investment in partnerships, enhancing Williams’ LNG capabilities and global market access.
The Power Innovation sector grew significantly, with $5.1 billion in committed capital backed by long-term agreements, supporting the company's transition to cleaner energy solutions.

View recap

22nd Century Group, Inc.

XXII Q3 2025

Reported: 2025-11-05

22nd Century Group reports significant progress in Q3 2025, achieving a debt-free status and transitioning towards a higher-margin branded product strategy after completing a comprehensive restructuring.

Key takeaways

Successfully eliminated all debt, providing a strengthened balance sheet and financial stability.
Shift in strategy focusing on higher-margin branded products with a gradual exit from low-margin contract manufacturing.
Implemented critical changes in manufacturing operations aimed at enhancing cost structure and profitability.
Continued dedication to Tobacco Harm Reduction, positioning low-nicotine products to address nicotine addiction effectively.
Expansion of product offerings to enhance brand recognition and support sales across both full nicotine and very low nicotine segments.

View recap

Zepp Health Corporation

ZEPP Q3 2025

Reported: 2025-11-05

Zepp Health Corporation reported robust third-quarter results, showcasing a 78.5% year-over-year revenue growth and a significant shift to operational cash inflow, demonstrating strong product demand and effective strategic execution.

Key takeaways

Revenue soared 78.5% year-over-year, driven by successful product launches and strong brand recognition.
Gross margin expanded from 36.2% to 38% due to effective mix management and ongoing margin improvement initiatives.
Launched the Amazfit T-Rex 3 Pro, well-received by the outdoor community; recognized performance via athlete endorsement during high-profile events.
Acquired Wild.AI, enhancing offerings in women's wellness and personalized coaching experiences.
Continuous integration of Zepp OS enhancements improves user experience with AI-driven insights and expanded training capabilities.

View recap

Zeta Global Holdings Corp.

ZETA Q3 2025

Reported: 2025-11-05

Zeta's Q3 '25 results showcase continued momentum, achieving $337 million in revenue (up 28% YoY) and a record free cash flow margin of 14%, as the company propels forward with its AI-driven marketing solutions.

Key takeaways

Adjusted EBITDA of $78 million reflects a robust 46% YoY growth, demonstrating improved profitability.
The successful Zeta Live event drew a record audience, increasing attendance by 35%, signifying strong interest in Zeta's offerings.
Launch of Athena, an AI superintelligent agent, positions Zeta at the forefront of marketing technology, enhancing client interaction and operational efficiency.
Ongoing integration of acquired technologies is expected to significantly boost OneZeta adoption, contributing to accelerated revenue growth into 2026.

View recap

Earnings Recaps

Accel Entertainment, Inc.

Axcelis Technologies, Inc.

Ascent Industries Co. Common Stock

Koninklijke Ahold Delhaize N.V.

ADTRAN, Inc.

agilon health, inc.

American International Group, Inc.

Assurant, Inc.

Advanced Micro Devices, Inc.

Arista Networks, Inc.

Ares Management Corporation

Ardmore Shipping Corporation

two

Astronics Corporation

Axon Enterprise, Inc.

Axsome Therapeutics, Inc.

Ball Corporation Common Stock

BB Seguridade Participacoes S.A.

BioCryst Pharmaceuticals, Inc.

Bunge Limited

TopBuild Corp.

BioNTech SE

BP p.l.c.

BP p.l.c.

Bruker Corporation

CareDx, Inc

Cipher Mining Inc. Common Stock

Clean Energy Fuels Corp.

COMPASS Pathways plc

Compass, Inc.

Cumberland Pharmaceuticals Inc.

Coupang, Inc.

Corebridge Financial, Inc.

Cricut, Inc.

Comstock Resources, Inc.

Corsair Gaming, Inc.

CT Real Estate Investment Trust

Coterra Energy Inc. Common Stock

Corteva, Inc.

Crexendo, Inc.

Dave Inc. Class A Common Stock

Delcath Systems, Inc.

Eastman Chemical Company

Emerson Electric Co.

Enel Chile S.A.

The Ensign Group, Inc.

Eaton Corporation plc

Entravision Communications Corporation

Vertical Aerospace Ltd.

Exelixis, Inc.

Diamondback Energy, Inc.

Fidelity National Information Services, Inc.

Flywire Corporation

Franco-Nevada Corporation

Amicus Therapeutics, Inc.

L.B. Foster Company

fuboTV Inc.

First Watch Restaurant Group Inc. Common Stock

Gibson Energy Inc.

Genius Sports Limited

Graphic Packaging Holding Company

Global Payments Inc.

The Hackett Group, Inc.

Hagerty, Inc.

Hippo Holdings Inc.

Harley-Davidson, Inc.

Harmony Biosciences Holdings, Inc.

Heron Therapeutics, Inc.

Humana Inc.

Hut 8 Corp.

Hut 8 Mining Corp.

IDEXX Laboratories, Inc.

Innovative Industrial Properties, Inc.

Iron Mountain Incorporated

Kinross Gold Corporation

Kinross Gold Corporation

Knife River Corporation

Karyopharm Therapeutics Inc.

Krystal Biotech, Inc.